RECOMBINANT DNA ENCODING A DESULFURIZATION BIOCATALYST

Abstract: This invention relates to a recombinant DNA molecule containing a gene or genes which encode a biocatalyst capable of desulfurizing a fossil fuel which contains organic sulfur molecules. For example, the present invention encompasses a recombinant DNA molecule containing a gene or genes of a strain of (Rhodococcus rhodochrous).

Description: RECOMBINANT DNA ENCODING A DESULFURIZATION BIOCATALYST BACKGROUND Sulfur contaminants in fossil fuels can create pro¬ blems in refinery processes which can be costly to recti- fy. The sulfur contaminants that occur in fossil fuels fall into either of the following general classes: miner¬ alized (inorganic, e.g., pyritic) sulfur and organic sulfur (sulfur that is covalently bound to carbonaceous molecules, referred to as organosulfur compounds) . The presence of sulfur has been correlated with corrosion of pipeline, pumping and refining equipment, and with pre¬ mature breakdown of combustion engines. Sulfur also poisons many catalysts which are used in the refining of fossil fuels. Moreover, the atmospheric emission of sulfur combustion products, such as sulfur dioxide, leads to the form of acid deposition known as acid rain. Acid rain has lasting deleterious effects on aquatic and forest ecosystems, as well as on agricultural areas located downwind of combustion facilities. Monticello, D.J. and W.R. Finnerty, (1985) Ann. Rev. Microbiol. 39:371-389. Regulations such as the Clean Air Act of 1964 require the removal of sulfur, either pre- or post-combustion, from virtually all coal- and petroleum-based fuels. Conformity with such legislation has become increasingly problematic due to the rising need to utilize lower grade, higher- sulfur fossil fuels as clean-burning, low-sulfur petroleum reserves become depleted, as well as the progressive reductions in sulfur emissions required by regulatory authorities. Monticello, D.J. and J.J. Kilbane, "Practi- cal Considerations in Biodesulfurization of Petroleum", IGT's 3d Intl. Sy p. on Gas. Oil, Coal, and Env. Biotech.. (Dec. 3-5, 1990) New Orleans, LA. One technique which is currently employed for the pre-combustion removal of organic sulfur from liquid fossil fuels, e.g., petroleum, is hydrodesulfurization (HDS) . HDS is suitable for the desulfurization of fossil fuels wherein organosulfur compounds account for a signi¬ ficant, e.g., a major, proportion of all sulfur contam- inants present. HDS is thus useful for treating crude oil or bitumen, petroleum distillate fractions or refining intermediates, liquid motor fuels, and the like. HDS is more particularly described in Shih, S.S. et al. , "Deep Desulfurization of Distillate Components", Abstract No. 264B AIChE Chicago Annual Meeting, presented November 12, 1990, (complete text available upon request from the American Institute of Chemical Engineers) ; Gary, J.H. and G.E. Handwerk, (1975) Petroleum Refining: Technology and Economics. Marcel Dekker, Inc., New York, pp. 114-120, and Speight, J.G. , (1981) The Desulfurization of Heavy Oils and Residue. Marcel Dekker, Inc., New York, pp. 119-127. HDS is based on the reductive conversion of organic sulfur into hydrogen sulfide (H 2 S) in the presence of a metal catalyst. HDS is carried out under conditions of elevated temperature and pressure. The hydrogen sulfide produced as a result of HDS is a corrosive gaseous substance, which is stripped from the fossil fuel by known techniques. Elevated or persistent levels of hydrogen sulfide are known to poison (inactivate) the HDS catalyst, complicat- ing the desulfurization of liquid fossil fuels that are high in sulfur. Organic sulfur in both coal and petroleum fossil fuels is present in a myriad of compounds, some of which are termed labile in that they can readily be desulfur- ized, others of which are termed refractory in that they do not easily yield to conventional desulfurization treat¬ ment, e.g., by HDS. Shih, S.S. et al. Frequently, then, even HDS-treated fossil fuels must be post-combustively desulfurized using an apparatus such as a flue scrubber. Flue scrubbers are expensive to install and difficult to maintain, especially for small combustion facilities. Moreover, of the sulfur-generated problems noted above, the use of flue scrubbers in conjunction with HDS is directed to addressing environmental acid deposition, rather than other sulfur-associated problems, such as corrosion of machinery and poisoning of catalysts. Recognizing these and other shortcomings of HDS, many investigators have pursued the development of microbial desulfurization (MDS) . MDS is generally described as the harnessing of metabolic processes of suitable bacteria to the desulfurization of fossil fuels. Thus, MDS typically involves mild (e.g., ambient or physiological) conditions, and does not involve the extremes of temperature and pressure required for HDS. It is also generally con¬ sidered advantageous that biological desulfurizing agents can renew or replenish themselves under suitable con¬ ditions. Microbial desulfurization technology is reviewed in Monticello and Finnerty (1985), 39 ANN. REV. MICROBIOL. 371-389 and Bhadra et al. (1987), 5 BIOTECH. ADV. 1-27. Hartdegan et al. (1984), 5 CHEM. ENG. PROGRESS 63-67 and Kilbane (1989), 7 TRENDS BIOTECHNOL. (No. 4) 97-101 pro¬ vide additional commentary on developments in the field. Several investigators have reported mutagenizing naturally-occurring bacteria into mutant strains with the acquired capability of breaking down, i.e., catabolizing, dibenzothiophene (DBT) . Hartdegan, F.J. et al., (May 1984) Chem. Eng. Progress 63-67. DBT is representative of the class of organic sulfur molecules found in fossil fuels from which it is most difficult to remove sulfur by HDS. Most of the reported mutant microorganisms act upon DBT nonspecifically, by cleaving carbon-carbon bonds, thereby releasing sulfur in the form of small organic breakdown products. One consequence of this microbial action is that the fuel value of a fossil fuel so treated is degraded. Isbister and Doyle, however, reported the derivation of a mutant strain of Pseudomonas which ap¬ peared to be capable of selectively liberating sulfur from DBT, thereby preserving the fuel value of treated fossil fuels. U.S. Patent No. 4,562,156. Kilbane recently reported the mutagenesis of a mixed bacterial culture, producing a bacterial consortium which appeared capable of selectively liberating sulfur from DBT by an oxidative pathway. Resour. Cons. Recvcl. 3:69-79 (1990) . A strain of Rhodococcus rhodocrous was sub¬ sequently isolated from the consortium. This strain, which has been deposited with the American Type Culture Collection under the terms of the Budapest Treaty as ATCC No. 53968 and also referred to as IGTS8, is a source of biocatalytic activity as described herein. Microorganisms of the ATCC No. 53968 strain liberate sulfur from forms of organic sulfur known to be present in fossil fuels, in- eluding DBT, by the selective, oxidative cleavage of carbon-sulfur bonds in organic sulfur molecules. Kilbane has described the isolation and characteristics of this strain in detail in U.S. Patent No. 5,104,801. SUMMARY OF THE INVENTION This invention relates in one aspect to a deoxyribo- nucleic acid (DNA) molecule containing one or more genes encoding one or more enzymes that, singly or in concert with each other, act as a biocatalyst that desulfurizes a fossil fuel that contains organic sulfur molecules. The DNA molecule of the present invention can be purified and isolated from a natural source, or can be a fragment or portion of a recombinant DNA molecule that is, e.g., integrated into the genome of a non-human host organism. The gene or genes of the present invention can be obtained from, e.g., a strain of Rhodococcus rhodochrous micro¬ organisms having suitable biocatalytic activity. That is, the gene or genes of the present invention can be obtained from a non-human organism, e.g., a microorganism, that expresses one or more enzymes that, singly or in concert with each other, act as a desulfurizing biocatalyst. Biocatalysis, as described more fully below, is the selec¬ tive oxidative cleavage of carbon-sulfur bonds in organo- sulfur compounds. The present invention is particularly useful for the desulfurization of fossil fuels that con- tain organosulfur compounds, e.g., DBT. The invention further relates to recombinant DNA vectors, recombinant DNA plasmids and non-human organisms that contain foreign (recombinant, heterologous) DNA encoding a biocatalyst capable of desulfurizing a fossil fuel which contains organosulfur compounds. Such organ¬ isms are referred to herein as host organisms. The invention described herein thus encompasses ribonucleic acid (RNA) transcripts of the gene or genes of the present invention, as well as polypeptide expression product(s) of the gene or genes of the present invention. The present polypeptide expression products, after such post-translational processing and/or folding as is neces¬ sary, and in conjunction with any coenzymes, cofactors or coreactants as are necessary, form one or more protein biocatalysts (enzymes) that, singly or in concert with each other, catalyze (promote, direct or facilitate) the removal of sulfur from organosulfur compounds that are found in fossil fuels. This is accomplished by the selec¬ tive, oxidative cleavage of carbon-sulfur bonds in said compounds. The biocatalyst of the present invention can be a non-human host organism, viable (e.g., cultured) or non-viable (e.g., heat-killed) containing the DNA of the present invention and expressing one or more enzymes encoded therein, or it can be a cell-free preparation derived from said organism and containing said one or more biocatalytic enzymes. In another aspect, the present invention relates to a method of desulfurizing a fossil fuel using the above mentioned non-human organism, said organism expressing a desulfurizing biocatalyst. Alternatively, the present invention relates to a method of desulfurizing a fossil fuel using a biocatalyst preparation comprising one or more enzymes isolated from said organism. The process involves: 1) contacting said organism or biocatalyst preparation obtained therefrom with a fossil fuel that contains organic sulfur, such that a mixture is formed; and 2) incubating the mixture for a sufficient time for the biocatalyst expressed by or prepared from the organism to desulfurize the fossil fuel. The biocatalytically treated fossil fuel obtained following incubation has significantly reduced levels of organosulfur compounds, compared to a sample of the corresponding untreated fossil fuel. In yet another aspect, the invention relates to nucleic acid probes which hybridize to the recombinant DNA of the present invention. In still other aspects, the present invention relates to the production of new non-human organisms containing the recombinant DNA of the present invention and prefer¬ ably expressing the biocatalyst encoded therein. Avail- ability of the recombinant DNA of this invention greatly simplifies and facilitates the production and purification of biocatalysts for desulfurizing a fossil fuel. Costly and time consuming procedures involved in the purification of biocatalysts can be reduced, eliminating the need to generate the biocatalyst from one or more non-human organ¬ isms in which it is naturally present or has been produced by mutagenesis. More specifically, non-human host organ¬ isms can be generated which express the gene or genes of the present invention at elevated levels. In addition, the invention described herein furthers the discovery of genes encoding desulfurization biocatalysts in additional non-human organisms. This objective can be accomplished using the nucleic acid probes of the present invention to screen DNA libraries prepared from one or more additional non-human organisms in whom biocatalytic function is known or suspected to be present. Any genes present in such organisms and encoding desulfurization biocatalysts or components thereof can be replicated at large scale using known techniques, such as polymerase chain reaction (PCR) . PCR advantageously eliminates the need to grow the non- human organisms, e.g., in culture, in order to obtain large amounts of the DNA of interest. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a flow diagram schematic illusting a stepwise procedure for the isolation of the recombinant DNA of the present invention. Figure 2 is a schematic illustration of the Rhodo¬ coccus rhodochrous replication competent and chloram- phenicol resistant vector pRF29, said vector having been derived from Rhodococcus fascians. Figure 3 is a schematic illustration of the Rhodo¬ coccus rhodochrous replication competent and chloram- phenicol resistant vector pRR-6. Figure 4 is a schematic illustration of the restric¬ tion map for DNA plasmid pTOXI-1 encoding a biocatalyst capable of carbon-sulfur bond cleavage. Figure 5 is a schematic illustration of the restric¬ tion map for subclone pMELV-1, derived from plasmid pTOXI- 1. Figure 6 is a schematic illustration of the reεtric- tion map for pMELV-1 and fragments thereof present as inserts in subclones pSMELV-lA, pSMELV-2A, pSMELV-3A and PSMELV-4A. Figure 7 is a schematic illustration of the predicted locations within the sequence of pTOXI-1 of three nearly contiguous open reading frames (ORFs; specifically, ORF 1, ORF 2 and ORF 3) encoding polypeptide expression products responsible for the Dsz+ phenotype. Figure 8 is a schematic illustration of the restric¬ tion map of pTOXI-1 and fragments thereof present as inserts in subcloneε pENOK-1, pENOK-2, pENOK-3, pENOK-11, pENOK-13, pENOK-16, pENOK-18, pENOK-Nsi. pENOK-19 AND pENOK-20. Figure 9 is a schematic illustration of the restric¬ tion map of pRR-12. Figure 10 is a schematic illustration of the restric¬ tion map of vector pKAMI. In the inset, the engineered cloning site present in pKAMI is shown in detail. Figure 11 is a schematic illustration of the restric¬ tion map of pSBG-2, in which expression of a promoterless Dsz gene cluster from pTOXI-1 is driven by the chloram- phenicol resistance promoter. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT In the petroleum extraction and refining arts, the term "organic sulfur" is generally understood as referring to organic molecules having a hydrocarbon framework to which one or more sulfur atoms (called heteroatoms) are covalently joined. These sulfur atoms can be joined directly to the hydrocarbon framework, e.g., by one or more carbon-sulfur bonds, or can be present in a sub- stituent joined to the hydrocarbon framework of the mole¬ cule, e.g., a sulfonyl group (which contains a carbon- oxygen-sulfur covalent linkage) . The general class of organic molecules having one or more sulfur heteroatoms are sometimes referred to as "organosulfur compounds". The hydrocarbon portion of these compounds can be ali¬ phatic, aromatic, or partially aliphatic and partially aromatic. Cyclic or condensed multicyclic organosulfur com¬ pounds in which one or more sulfur heteroatoms are linked to adjacent carbon atoms in the hydrocarbon framework by aromatic carbon-sulfur bonds are referred to as "sulfur- bearing heterocycleε". The sulfur that iε present in many types of sulfur-bearing heterocycles iε referred to as "thiophenic sulfur" in view of the five-me bered aromatic ring in which the sulfur heteroatom iε preεent. The simpleεt εuch εulfur-bearing heterocycle iε thiophene, which haε the compoεition C 4 H 4 S. Sulfur-bearing heterocycleε are known to be εtable to conventional deεulfurization treatmentε, such aε HDS. For thiε reaεon, they are said to be refractory or recalci¬ trant to HDS treatment. Sulfur-bearing heterocycles can have relatively simple or relatively complex chemical structures. In complex heterocycles, multiple condensed aromatic rings, one or more of which can be heterocyclic, are present. The difficulty of deεulfurization increaεes with the structural complexity of the molecule. Shih et al. That iε, refractory behavior is most accentuated in complex sulfur-bearing heterocycles, such as dibenzo- thiophene (DBT, C 12 H 8 S) . DBT is a sulfur-bearing heterocycle that has a con¬ densed, multiple aromatic ring structure in which a five- membered thiophenic ring is flanked by two six-membered benzylic rings. Much of the residual post-HDS organic sulfur in fossil fuel refining intermediates and com- bustible products is thiophenic sulfur. The majority of this residual thiophenic sulfur is present in DBT and derivativeε thereof having one or more alkyl or aryl radicals attached to one or more carbon atoms present in one or both flanking benzylic rings. Such DBT derivatives are said to be "decorated" with these radicals. DBT itself is accepted in the relevant arts as a model com¬ pound illustrative of the behavior of the class of com¬ pounds encompassing DBT and alkyl- and/or aryl-decorated derivatives thereof in reactions involving thiophenic εulfur. Monticello and Finnerty (1985) , Microbial desul¬ furization of fossil fuels. 39 ANNUAL REVIEWS IN MICRO¬ BIOLOGY 371-389, at 372-373. DBT and radical-decorated derivatives thereof can account for a εignificant per¬ centage of the total εulfur content of particular crude oilε, coalε and bitumen. For example, theεe sulfur-bear¬ ing heterocycles have been reported to account for as much aε 70 wt% of the total sulfur content of West Texas crude oil, and up to 40 wt% of the total sulfur content of some Middle East crude oilε. Thuε, DBT iε conεidered to be particularly relevant as a model compound for the forms of thiophenic sulfur found in fossil fuels, εuch as crude oils, coals or bitumen of particular geographic origin, and various refining intermediates and fuel products manufactured therefrom. Id. Another characteristic of DBT and radical-decorated derivatives thereof is that, following a release of fosεil fuel into the environment, theεe εulfur-bearing heterocycles persiεt for long periods of time without εignificant biodegradation. Gundlach et al. (1983), 221 SCIENCE 122-129. Thuε, moεt prevalent naturally occuring microorganisms do not effectively metabolize and break down sulfur-bearing heterocycles. A fosεil fuel that iε εuitable for desulfurization treatment according to the present invention is one that containε organic εulfur. Such a foεεil fuel is referred to as a "εubεtrate fossil fuel". Substrate fossil fuels that are rich in thiophenic sulfur (wherein a significant fraction of the total organic sulfur is thiophenic εulfur, present in sulfur-bearing heterocycles, e.g., DBT) are particularly suitable for desulfurization according to the method described herein. Examples of such subεtrate foεsil fuels include Cerro Negro or Orinoco heavy crude oils; Athabascan tar and other types of bitumen; petroleum refining fractions such as light cycle oil, heavy atmos¬ pheric gas oil, and No. 1 diesel oil; and coal-derived liquids manufactured from εourceε εuch aε Pocahontaε #3, Lewis-Stock, Auεtralian Glencoe or Wyodak coal. Biocatalytic deεulfurization (biocatalyεiε or BDS) is the exciεion (liberation or removal) of sulfur from or¬ ganosulfur compounds, including refractory organosulfur compounds such aε sulfur-bearing heterocycles, as a result of the selective, oxidative cleavage of carbon-sulfur bonds in said compounds by a biocatalyst. BDS treatment yieldε the d esulfurized combustible hydrocarbon framework of the former refractory organosulfur compound, along with inorganic sulfur — substanceε which can be readily sepa ¬ rated from each other by known techniques such as fra- tional diεtillation or water extraction. For example, DBT is converted into hydroxybiphenyl or dihydroxybiphenyl, or a mixture thereof, when subjected to BDS treatment. BDS is carried out by a biocatalyst comprising one or more non-human organisms (e.g., microorganismε) that function- ally expreεε one or more enzymes that direct, singly or in concert with each other, the removal of sulfur from or¬ ganosulfur compounds, including sulfur-bearing hetero- cycleε, by the selective cleavage of carbon-εulfur bonds in said compounds; one or more enzymes obtained from such microorganisms; or a mixture of such microorganisms and enzymes. Organisms that exhibit biocatalytic activity are referred to herein as being CS+ or Dsz+. Organisms that lack biocatalytic activity are referred to herein as being CS- or Dsz-. As summarized above, the invention described herein relates in one aεpect to a DNA molecule or fragment there¬ of containing a gene or genes which encode a biocatalyst capable of desulfurizing a fossil fuel that contains organosulfur compounds. The present DNA molecule or fragment thereof can be purified and isolated DNA obtained from, e.g., a natural source, or can be recombinant (het¬ erologous or foreign) DNA that is, e.g., present in a non- human hoεt organiεm. The following diεcuεsion, which is not to be construed as limiting on the invention in any way but is presented for purposeε of illustration, re¬ counts the isolation of DNA encoding a desulfurizing biocatalyst from a strain of Rhodococcus rhodochrouε. ATCC No. 53968, that is known to express εuitable biocatalytic activity. Thiε preferred εtrain of Rhodococcus rhodocrous iε diεclosed in U.S. Patent No. 5,104,801 (issued 1992), the teachings of which are incorporated herein by refer- ence, and haε been referred to in the literature aε IGTS8. IGTS8 was developed by investigatorε at the Institute of Gas Technology in Chicago IL. Other organiεms that are known to express suitable biocatalytic activity and thus are viewed as suitable sources of the DNA of the present invention include the strain of Bacillus εulfasportare described in U.S. Patent 5,002,888 and deposited with the American Type Culture Collection as ATCC No. 53969 and the Corvnebacterium strain described in Omori et al. (1992) , Desulfurization of dibenzothiophene by Corvnebacterium εp. εtrain SY1. 58 APPL. ENV. MICROBIOL. (No. 3) 911-915. The isolation of the DNA of the present invention from the ATCC No. 53968 microorganism is schematically depicted in Figure 1, and will now be described. Mutant strains of R. rhodochrous that are incapable of cleaving carbon-εulfur bondε (CS- or Dεz-) , are pro¬ duced by exposing a strain of R. rhodochrous. e.g., ATCC No. 53968, that exhibits biocatalytic activity (that is CS+ or Dsz+) , to a mutagen under appropriate conditions that are known to or readily ascertainable by thoεe skilled in the art. Suitable mutagenε include radiation, e.g., ultraviolet radiation, and chemical mutagenε, e.g., N-methyl-N'-nitrosoguanidine (NTG) , hydroxylamine, ethyl- methaneεulphonate (EMS) and nitrouε acid. Mutants thus formed are allowed to grow in an appropriate medium and screened for carbon-sulfur bond cleavage activity. Mu¬ tants identified as lacking carbon-εulfur bond cleavage activity are termed CS-. Any method of εcreening which allows for an accurate detection of carbon-sulfur bond cleavage activity is suitable in the method of the preεent invention. Suitable methods of screening for thiε activ¬ ity include exposing the different mutants to carbon- sulfur bond containing molecules (e.g., DBT) and measuring carbon-sulfur bond cleavage. In a preferred embodiment, the mutants are exposed to DBT, such that the breakdown product, hydroxybiphenyl (HBP) , which fluoresceε under εhort wave ultraviolet light, iε produced. HBP can alεo be detected colorimetrically through its blue reaction product with Gibbs' reagent. Other methods include gas and liquid chromatography, infrared and nuclear magnetic reεonance spectrometry. See Kodama, et al.. Applied and Environmental Microbiology, pages 911-915 (1992) and Kilbane and Bielaga, Final Report D.O.E. Contract No. DE- AC22-88PC8891 (1991) . Once CS- mutants are identified and isolated, clones thereof are propagated using standard techniqueε and subjected to further analysis. Concurrent with the mutagenesiε of the above-des¬ cribed culture of the CS+ organism, R. rhodochrous. a second culture of the same CS+ organism (1) is maintained in culture. CS+ organism DNA (3) is extracted from this culture of R. rhodocrous. Various methods of DNA extrac¬ tion are suitable for isolating the DNA of this organiεm. Suitable methods include phenol and chloroform extraction. See Maniatis et al.. Molecular Cloning. A Laboratory Manual. 2d. Cold Spring Harbor Laboratory Press, page 16.54 (1989), herein referred to as Maniatis et' al.. Once the DNA is extracted from R. rhodochrous 1, the DNA (3) is cut into fragments of various kilobase lengths, which collectively make up DNA library 5. Various methods of fragmenting the DNA of R. rhodochrous to purify DNA therefrom, including the DNA of the present invention, can be used, e.g., enzymatic and mechanical methods. Any four-baεe recognition restriction endonucleaεe such aε TaqI or Sau 3A is suitable for fragmenting the DNA. Suitable methods of fragmenting DNA can be found in Mani- atis et al.. The various DNA fragments are inserted into several CS- mutant cloneε of R. rhodochrous (2 ) , with the purpoεe of iεolating the fragment of DNA that encodeε the bio¬ catalyst of the present invention. The transformation of a previously CS- mutant cell to a CS+ tranεformed cell iε evidence that the inεerted DNA fragment encodes a bio- catalyεt. Any method of inserting DNA into R. rhodochrous which allows for the uptake and expresεion of said frag¬ ment is suitable. In a preferred embodiment, electro- poration is used to introduce the DNA fragment into . rhodochrouε. See Maniatis et al.. Once transformed, CS+ mutant R. rhodochrous 7 has been produced and identified, DNA fragment 9 encoding the CS+ biocatalyst can be identified and isolated. The encoded biocatalyst can then be produced uεing the iso- lated DNA in various methods that are well known and readily available to those skilled in the art. In ad¬ dition, the isolated DNA can be sequenced and replicated by known techniqueε, e.g., the techniques described in Maniatis et al.. As noted previously, the above-described method for isolating the DNA of the present invention can be applied to CS+ organisms other than R. rhodocrous microorganismε, e.g., of the εtrain ATCC No. 53968. Thuε, Bacillus sulfa- sportare ATCC No. 53969 or Corvnebacterium εp. SY1 can be used as the source organism for the DNA of the present invention. Furthermore, once isolated, the DNA of the present invention can be transfected into a non-human host organism other than a CS- mutant of the source organism. Thus, the DNA of the present invention can be transfected into, e.g., a suitable strain of Escherichia coli bacte¬ ria. Other typeε of non-human hoεt organiεm can alεo be uεed, including unicellular organiεmε (e.g., yeaεt) and cellε eεtabliεhed in culture from multicellular organiεmε. Other methodε of iεolating the DNA of the present invention, include variations on the rationale described above and depicted in Figure 1. For example, it would be poεεible to randomly inεert a CS- DNA plaε id into cloneε of a CS+ strain of R. rhodochrous. DNA encoding a CS+ biocatalyεt could then be identified by εcreening for cloneε that have been tranεformed from CS+ to CS-. The recombinant DNA molecule or fragment thereof of the present invention is intended to encompass any DNA resulting from the insertion into its chain, by chemical or biological means, of one or more genes encoding a biocatalyst capable of selectively cleaving carbon-sulfur bondε, said gene not originally present in that chain. Recombinant DNA includes any DNA created by procedures using restriction nucleaseε, nucleic acid hybridization, DNA cloning, DNA sequencing or any combination of the preceding. Methods of construction can be found in Man- iatiε et al.. and in other methodε known by thoεe εkilled in the art. Procedures for the construction of the DNA plasmidε or vectorε of the preεent invention include thoεe deε- cribed in Maniatis et al. and other methods known by those skilled in the art. Suitable plasmid vectors include pRF- 29 and pRR-6 depicted in Figures 2 and 3, respectively. The terms "DNA plasmid" and "vector" are intended to encompasε any replication competent plaεmid or vector capable of having foreign or exogenous DNA inserted into it by chemical or biological meanε and subεequently, when tranεfected into an appropriate non-human hoεt organiεm, of expressing the product of the foreign or exogenous DNA insert (i.e., of expresεing the biocatalyεt of the preεent invention) . In addition, the plaεmid or vector muεt be receptive to the inεertion of a DNA molecule or fragment thereof containing the gene or geneε of the preεent inven¬ tion, εaid gene or genes encoding a biocatalyst that selectively cleaves carbon-sulfur bonds in organosulfur compounds. Procedures for the conεtruction of DNA plaεmid vectorε include thoεe deεcribed in Maniatiε et al. and otherε known by thoεe εkilled in the art. The plaεmidε of the preεent invention include any DNA fragment containing a gene or geneε encoding a biocatalyst that selectively cleaves carbon-sulfur bondε in organo- εulfur compoundε. The term "plaεmid" iε intended to encompass any DNA fragment. The DNA fragment should be transmittable to a host microorganism by transformation or conjugation. Procedures for the construction or extrac¬ tion of DNA plasmids include those described in Maniatis et al. and others known by those skilled in the art. The transformed non-human hoεt organiεmε of the preεent invention can be created by variouε methods by those skilled in the art. For example, transfection electroporation as explained by Maniatiε et al. can be uεed. By the term "non-human hoεt organiεm" iε intended any non-human organism capable of the uptake and expreε- εion of foreign, exogenouε or recombinant DNA, i.e., DNA not originally a part of the organiεm'ε nuclear material. The method of desulfurizing a foεεil fuel of the preεent invention involves two aspectε. Firεt, a hoεt organism or biocatalytic preparation obtained therefrom is contacted with a fosεil fuel to be deεulfurized. Thiε can be done in any appropriate container, optionally fitted with an agitation or mixing device. The mixture iε com- bined thoroughly and allowed to incubate for a sufficient time to allow for cleavage of a significant number of carbon-εulfur bonds in organosulfur compounds, thereby producing a desulfurized fossil fuel. In one embodiment, an aqueous emulsion is produced with an aqueous culture of the organism and the fosεil fuel, allowing the organism to propagate in the emulsion while the expressed biocatalyst cleaves carbon-sulfur bonds. Variables such as temperature, mixing rate and rate of deεulfurization will vary according to the organism uεed. The parameterε can be determined through no more than routine experimentation. Several εuitable techniques for monitoring the rate and extent of desulfurization are well-known and readily available to those skilled in the art. Baseline and timecourse samples can be collected from the incubation mixture, and prepared for a determination of the residual organic εulfur in the foεεil fuel. The disappearance of sulfur from organosulfur compounds, such as DBT, in the εample being εubjected to biocatalytic treatment can be monitored uεing, e.g., X-ray fluoreεcence (XRF) or atomic emisεion εpectrometry (flame spectrometry) . Preferably, the molecular componentε of the εample are firεt εepa- rated, e.g., by gaε chromatography. The nucleic acid probeε of the present invention include any nuclear material capable of hybridizing to at least a portion of the DNA of the present invention. The term "nucleic acid probe" includes any nuclear material capable of hybridizing to DNA. The invention will now be further illuεtrated by the following εpecific Exampleε, which are not to be viewed aε limiting in any way. EXAMPLE 1. ISOLATION OF DNA ENCODING A DESULFURIZATION ACTIVE BIOCATALYST. As used herein, the term "Dεz+" referε to the ability of an organism to utilize thiophenic compoundε such as dibenzothiophene (DBT) as the εole εource of εulfur by the εelective cleavage of carbon-εulfur bondε therein. Rhodo¬ coccus rhodochrous strain IGTS8 demonstrateε the Dsz + phenotype. The term "Dsz-" referrs to an organism's inability to utilize said thiophenic compounds as a sole source of εulfur by the selective cleavage of carbon- sulfur bonds therein. Materials Bacterial strainε and plasmids Rhodococcus rhodochrous strain IGTS8 (ATCC No. 53968) , obtained from the Institute of Gas Technology (Chicago, IL) , waε uεed as a parent strain for production of mutant strainε which have lost the desulfurization phenotype (Dsz-) . Strain IGTS8 was also used for iso¬ lation of DNA fragments capable of complementing said mutantε to produce Dsz+ mutants therefrom. Rhodococcus vector pRF-29 was obtained from the Inεtitute of Gaε Technology. The conεtruction of pRF-29 iε described in Desomer, et al. (1990), Tranεformation of Rhodococcus faεcians bv High-Voltage Electroporation and Development of R. fascians Cloning Vectors. APPLIED AND ENVIRONMENTAL MICROBIOLOGY 2818-2825. The structure of pRF-29 is sche¬ matically depicted in Figure 2. Escherichia coli εtrain JM109 was used aε a host in transformation with plasmid constructε derived from the plaεmidε pUC18 and pUC19 (Betheεda Research Laboratories, Bethesda, MD) . Enzvmeε and Reagents Restriction endonucleaseε were purchaεed from Bethesda Research Laboratories (BRL) and New England Biolabs (Beverly, MA) . T4 ligaεe and the Klenow fragment of E. coli DNA polymerase I were purchased from BRL. HK™ Phosphataεe waε purchaεed from Epicentre Technologieε (Madiεon, WI) . All enzymes were used in accordance with manufacturers recommendations. Enzyme asεay subεtrateε Dibenzothiophene (DBT) , Dibenzothiophene 5-oxide (DBT sulfoxide) and Dibenzothiphene sulfone (DBT sulfone) were purchased from Aldrich (Milwaukee, WI) . Gibb's Reagent, 2,6-dicholoroquinone-4-chloroimide, was purchased from Sigma (St. Louis, MO). Chemical mutagen N-methyl-N 1 - nitro-N-nitrosoguanidine (NTG) waε alεo purchaεed from Sigma. Growth Media and Conditionε E. coli JM109 waε grown in L-broth (Difco, Detroit, MI) . Tranεformantε were εelected on L-plateε supplemented with 1.5% agar and containing 125μg/ml ampicillin. E. coli strainε were grown at 37"C. Rhodococcuε strains were maintained on Rhodococcus Media (RM) composed per liter of: 8.0g Nutrient Broth (Difco), 0.5g yeast extract, 10.Og glucose. Transformants of Rhodococcus strains were se¬ lected on RM plates supplemented with 1.5% agar and con¬ taining 25μg/ml chloramphenicol. For expression of the Dsz+ phenotype, Rhodococcuε strainε were grown in Baεal Saltε Media (BSM) compoεed per liter of: 2.44g KH 2 P0 4 , 5.57g Na 2 HP0 4 2.Og NH^Cl, 0.2 g MgCl 2 .6H 2 0, O.OOlg CaCl 2 .2H 2 0, O.OOlg FeCl 3 6H 2 0, 0.004g MnCl 2 .4H 2 0, 6.4ml glycerol. Optionally, BSM can be εupplemented with 5.0g/liter glucose. Rhodococcus strains were grown at 30°C. Methods Sulfur Bioavailability Assay The sulfur bioavailability assay, described in U.S. Patent 5,104,801, examines an organiεm's ability to liber- ate organically bound sulfur from subεtrateε (e.g., DBT, DBT εulfoxide, DBT εulfone) for uεe as the sole εource of εulfur for growth. In the assay, BSM, which contains no sulfur, is supplemented with one or more sulfur containing substrateε, e.g., DBT. The organiεm's ability to liberate sulfur therefrom is measured by itε ability to grow with proper incubation, aε monitored by optical denεity at 600 nm. Gibbε Aεεay for 2-Hydroxybiphenyl The oxidative product of DBT, DBT sulfoxide and DBT sulfone incubated with strain IGTS8 is 2-hydroxybiphenyl (2-HBP) . The Gibbs assay colorimetrically quantitates the amount of 2-HBP produced from DBT and its above-mentioned oxidative derivatives. The asεay measures 2-HBP produced in culture supernatants after incubation with DBT. The media must be adjuεted to pH 8.0 before the Gibb's reagent is added. Gibb's Reagent, 2,6- dicholoroquinone-4-chloro- imide (lOmg/ml in ethanol) , is added to culture super¬ natants at 1:100 (v/v) . Color development is measured as abεorbance at 610nm after a 30 minute incubation at room temperature. HPLC Assay for 2-Hvdroxybiphenyl 2-HBP production cultures incubated with DBT can also be detected by HPLC using instrumentation available from Waters, Millipore Corporation, Milford, MA. Reagent alcohol iε added to culture broth at 1:1 (v/v) in order to solubilize all remaining DBT and 2-HBP. Sampleε are agitated for 5 min at 220 rpm. Extracted broth samples are removed and centrifuged to remove cellular masε. Clarified εupernatantε are then analyzed by HPLC with the following conditionε: Mobile Phase: Isocratic 70% Acetonitrile 1.5ml/min Retention timeε: DBT 4.5 minuteε 2-HBP 2.9 minutes IGTS8 Mutageneεis In order to generate mutant strains of R. rhodochrous which did not metabolize DBT (Dsz- mutants) , biocatalyst εource εtrain IGTS8 (Dεz+) waε εubjected to mutageneεiε by εhort-wave UV light and to chemical mutageneεis with N- methyl-N'-nitro-N-nitroεoguanidine (NTG) . With UV ex- posure mutagenesis, a kill rate of greater than 99% was targeted. Continuously stirred R. rhodochrous cells at an optical density (A^) of 0.3 were subjected to UV expoεure from a Mineralight Lamp Model UVG-254 (Ultra-violet Pro- ductε. Inc., San Gabriel, CA) at a distance of 10 cm for 55 to 65 seconds to obtain this kill rate (97.9-99.9%). For NTG utagenesiε, cell εuεpenεionε were treated with 500 μg/ml NTG for a duration determined to achieve a kill rate of 30%-50%. Combination mutageneεiε utilizing both NTG and UV waε also done. For theεe an overall kill rate of greater than 99.9% waε uεed. Colonieε εurviving muta¬ geneεiε were picked onto RM plateε and εcreened for the Dεz- phenotype as deεcribed below. Screening Example A: Initially, a DBT-εpray plate εcreen was used to select Dsz- mutants. Mutant colonies were replica plated onto Basal Salts Media (BSM) electro- phoretic-grade agarose plates which contained no added sulfur. Colonies were allowed to grow at 30°C for 24hr. The plates were then sprayed with an even coating of 10% DBT dissolved in ether and incubated at 30"C for 90 min¬ utes. The plates were then wiped clean and observed under short-wave UV light. The observed end product of DBT metabolism, 2-hydroxybiphenyl (2-HBP) fluoresceε under short-wave UV light. Colonies that produce 2-HBP are thus identified by fluorescent spotε on the agaroεe. Colonieε that do not produce 2-HBP (that are Dεz-) do not produce fluorescent spots. Screening Example B: A εimpler variation of screening involved replica plating surviving mutagenized colonies to BSM agarose plates supplemented with 1.2ml/liter of a saturated ethanol solution of DBT. After 24 hours, pro¬ duction of 2-HBP can be visualized under UV illumination aε above. Mutantε which did not appear to produce 2-HBP by the above-deεcribed screening methodε were examined with the εulfur bioavailability aεsay, with DBT as the εole εource of εulfur. Growth of potential mutantε waε examined in 1.25ml liquid fermentations in BSM plus DBT media dis- penεed in 24-well plates (Falcon) . After a one day incu¬ bation at 30°C, 2-HBP production was monitored by the Gibbε colorimetric aεεay. Strains which continue to demonstrate the Dsz- phenotype were incubated in larger volumeε of BSM plus DBT and analyzed for 2-HBP or inter¬ mediates by the HPLC method. Because BSM is a defined minimal medium, a duplicate control culture which con¬ tained supplemental inorganic sulfur was grown in order to distinguiεh true Dεz- mutantε from auxotrophic mutants. Mutants which failed to grow in both the control and experimental media were assumed to be auxotrophic mutants. Of 1970 individually analyzed potential mutants, two were identified as Dsz-. One mutant, GPE-362, was gener- ated by NTG mutagenesiε. The other, CPE-648, waε gene¬ rated by combination NTG/UV mutagenesiε. Both GPE-362 and CPE-648 grow εlowly in sulfur bioavailability assayε, preεumably from trace amountε of sulfur on the glassware or in the media components. However, no detectable amounts of 2-HBP were produced by either mutant after an extended incubation of 6 to 10 days with DBT, as asεeεεed with either the Gibbs assay or the HPLC assay. Thus, independently produced R. rhodocrous IGTS8 mutantε GPE-362 and CPE-648 were Dεz- organiεmε. Vector Construction Vector constructs were derived from R. rhodochrous and confer chloramphenicol resiεtance. All conεtructs were developed in E. coli strain JM109. Transformation of JM109 was carried out with the Gene Pulsar (Bio-Rad Labo- ratorieε, Richmond, CA) according to manufacturer's recom¬ mendations. Plasmid isolation from JM109 waε performed by εtandard methodε (Birnboim and Doly (1979) , A rapid alka¬ line extraction procedure for εcreening recombinant plas¬ mid DNA. 7 NUCLEIC ACIDS RES. 1513-1523; Maniatis et al. (1982), MOLECULAR CLONING: A LABORATORY MANUAL (Cold Spring Harbor Laboratory Press) . Transformantε containing correct vector constructε were identified by reεtriction analyεis. Vector Construct A: pRR-6 (Figure 3) contains the Rhodo- coccus origin of replication and Chloramphenicol resis¬ tance marker (Cm R ) . The ori and Cm R have been removed from pRF-29 as a 6.9kb Xhol/Xba (partial) fragment. The ends were made blunt with Klenow and ligated to Sall/Xbal cut pKF39. pKF39 is pUClδ with the Small site replaced with a Bglll site. A unique Nari site is available for cloning in pRR-6. Nari ends are compatible with 4-base recognition endonuclease Taql. Transformation of Rhodococcuε rhodochrouε Transformation of IGTS8 and Dεz- mutantε thereof can be achieved by electroporation. The following conditionε were used in all transformations of Rhodococcuε rhodo¬ chrouε. Cellε were grown in RM to mid-log phase and harvested by centrifugation (5000xg) , then washed three times in cold, deionized, diεtilled water and concentrated 50-fold in 10% glycerol. The resulting cell concentrate could be used for electroporation directly or stored at - 80°C. Electroporations were carried out with the Gene Pulεer (Bio-Rad) apparatus. 100 μl cells were mixed with transformation DNA in a 2-mm gapped electrocuvette (Bio- Rad) and subjected to a 2.5 kV pulse via the pulεe con¬ troller (25 μF capacitor, 200 Q external reεistance) . Pulsed cells were mixed with 400 μ RM and incubated for 4 hourε at 30 β C with regular agitation. Cells were then plated to RM supplemented with proper antibiotic. When IGTS8 was tranεformed with pRF-29, chloram¬ phenicol reεiεtant colonies were cleanly selected at a frequency of 10 5 - 10 6 /μq DNA on plates containing 25 μg/ml chloramphenicol. Small Scale Plaεmid Preparation from R. rhodochrouε A εingle colony of Rhodococcus rhodochrous was uεed to inoculate 2 to 7ml of RM pluε 25 μg/ml chloramphenicol. The culture waε incubated for two dayε at 30°C with shak- ing. Cells were pelleted by centrifugation and resus¬ pended in 300 μl sucrose buffer (20% sucrose, 0.05 M Tris- Cl pH 8.0, 0.01 M EDTA 0.05 M NaCl, 10 mg/ml lysozyme) and incubated at 37°C for 1 hour. 300 μl Potaεsium acetate- acetate solution, pH 4.8 (60 ml 5 M KOAc, 11.5 ml Glacial acetic acid, 28.5 ml dH 2 0) , was added and the mixture waε gently mixed by inverεion. The mixture waε placed on ice for 5 minuteε and then cellular debris was pelleted by centrifugation. 500 μl supernatant was removed to a fresh tube to which RNAse was added to 0.05 μg/μl and incubated for 20 minutes at 37°C. The sample was then phenol:- chloroform extracted and the aqueous layer was precip¬ itated at -80°C with an equal volume of isopropanol. DNA was pelleted by centrifugation and resuεpended in 0.3 M NaOAc pH 8.0. DNA was precipitated again at -80°C with an equal volume of isopropanol. DNA waε pelleted by centri¬ fugation and resuspended in 0.3 M NaOAc pH 8.0. DNA was precipitated again at -80°C with two volumes of 95% EtOH. Pelleted DNA was washed with 70% EtOH and reεuεpended in 50 μl TE (Triε EDTA) . Iεolation of Genomic DNA from R. rhodochrouε Strain IGTS8 IGTS8 genomic DNA waε isolated as described. 20 ml RM was inoculated with a single colony of IGTS8 and incu¬ bated at 30°C for 48 hours with shaking at 220 rpm. Cells were harvested by centrifugation (5000xg) . Cells were resuspended in 10ml TE (10 mM Tris Base, 1 mM EDTA) with 100 mg lysozyme and incubated for 30 minutes at 30°C. Cells were lysed by adding 1 ml of 20% sodium dodecyl sulfate (SDS) . 10 ml of TE-saturated phenol and 1.5 ml 5 M NaCI were added immediately and the mixture waε gently agitated for 20 minutes at room temperature. Phenol waε removed by centrifugation, and the aqueouε layer waε extracted twice with an equal volume of chloroform. An equal volume of iεopropanol waε added to the aqueouε layer to precipitate the DNA. DNA waε spooled onto a paεteur pipette and rediεεolved in TE. DNA was then RNased with 20 μg/ml RNA for 1 hour at 37 β C. The sample was made to a final concentration of 100 mM NaCl and 0.4% SDS and pro¬ teased with 100 μg/ml protease K. The sample was then extracted with phenol and chloroform and precipitated with isopropanol as before. The purified genomic DNA, which included the DNA of the present invention, was resuspended in TE. Conεtruction of Plasmid Library of IGTS8 Genomic DNA from the Dsz+ source organism (IGTS8) waε cut with TaqI in order to produce fragmentε 0.5 - 23 kb in length. Cut DNA waε electrophoreεed through 0.8% low melting temperature agaroεe and DNA fragmentε greater than 5 kb in length were isolated and purified by standard methods (Maniatis, T. et al. (1982), MOLECULAR CLONING: A LABORATORY MANUAL (Cold Spring Harbor Laboratory Press)). Vector pRR-6 was cut with Nari to completion. The vector ends were dephosphorylated with HK™ phoεphataεe to pre¬ vent religation of the vector. The εize-fractioning genomic DNA waε ligated to cut and dephoεphorylated pRR-6. Molecular Complementation of Dεz- Mutant Strain CPE-648 Plasmid library ligations (above) were used to trans¬ form Dsz- mutant strain CPE-648 by electroporation as described. Negative control transformationε of CPE-648, which did not contain DNA (mock transformationε) , were also performed. After the four hour incubation in RM, the cells were spun out of suεpenεion by centrifugation and the εupernatant was removed. The cells were resuεpended in BSM with no sulfur. These cells were used to inoculate 250 ml of BSM supplemented with 300 μl of a saturated ethanol solution of DBT. By this procedure, clones which are capable of complementing the Dεz- mutation will be εelected by the εulfur bioavailability aεεay. Strainε containing the complementing sequenceε (i.e., the DNA of the preεent invention) will succeεεfully remove the sulfur from DBT and grow preferentially. After 6 days incubation at 30"C, the cultures were asεayed for 2-HBP by HPLC. Accumulation of 2-HBP waε detected in experimental cultureε while no accumulation of 2-HBP was detected in control cultures. The culture producing 2-HBP was spread onto RM plates supplemented with chloramphenicol to obtain single colonies that were harboring plasmids. These plateε were replica-plated to BSM agarose plates supplemented with 1.2 ml/liter of a saturated ethanol solution of DBT. After 24 hours in¬ cubation at 30°C, 2-HBP could be detected around some individual colonies under short wave UV illumination. These colonies presumably harbored plasmidε which com¬ plemented the Dεz- mutant by reεtoring the former Dεz+ phenotype. Characterization of Clones Complementing Dsz- Mutant CPE-648 Two independent plasmid libraries εucceεεfully com¬ plemented mutant CPE-648 to Dεz * aε described above. Plasmid DNA was isolated from single colonies which demon¬ strated 2-HBP production on BSM plus DBT plates (above) from cultures transformed with each of the two librarieε. Thiε plasmid DNA was used to transform E. coli strain JM109. Plaεmid DNA waε isolated and cut with restriction endonucleases in order to build a restriction map of the clones. Each of the two libraries yielded a single com¬ plementing clone. By restriction pattern similarities, the two cloneε appear to have overlapping sequences. These clones have been designated pTOXI-1 (Figure 4) and pTOXI-2, respectively. pTOXI-1 containε an inεert of approximately 6.6kb. pTOXI-2 contains an insert of ap¬ proximately 16.8kb. Complementation of Dsz ' Mutant GPE-362 Dsz- mutant GPE-362 was transformed with plaεmidε pTOXI-1 and pTOXI-2. Aε a control, GPE-362 waε alεo transformed with vector pRR-6. Transformants containing plasmid DNA were selected on RM plus chloramphenicol plateε. Cm R colonieε were transferred to BSM agaroεe plateε εupplemented with DBT. After 24 hr. incubation at 30°C, 2-HBP production could be seen around colonieε containing either pTOXI-1 or pTOXI-2 by εhort wave UV illumination. No 2-HBP could be detected around colonies containing only vector pRR-6. Overexpreεsion of the Dsz* Trait Upon Reintroduction of Cloned DNA Plasmidε pTOXI-1 and pTOXI-2 were tranεformed into Dsz- mutant εtrain CPE-648. Transformants containing plasmid DNA were selected on RM plus chloramphenicol plates. The specific activity of individual clones was examined by the following protocol. Single colonies of CPE-648 containing either pTOXI-1 or pTOXI-2 were used to inoculate 25 ml RM plus 25 μg/ml chloramphenicol in a 250 ml flask. As a positive control, parent strain IGTS8 was also grown in 25 ml RM. After 48 hours of growth at 30°C, 225 rpm shaking, 2.5 ml of the cultures were crossed into 25 ml BSM supplemented with 0.7 mM DMSO. Cultures were incubated for an additional 40 hours at 30°C. The optical density of each culture was measured at 600 nm against an appropriate blank. DBT was added to a final concentration of 150 μM and the cultures were incubated for 3 hours at 30°C. An equal volume of Reagent Alcohol (Baxter, McGaw Park, IL) waε then added to each culture to solubilize any remaining DBT or 2-HBP. A 1 ml sample was removed and cellular debris removed by -28- centrifugation. The supernatant was analyzed for 2-HBP by the HPLC aεεay deεcribed above. The εpecific activity is calculated aε mg of 2-HBP per liter/hours of incuba- tion/OD 600 . The resultε of the above assay is listed in Table 1. TABLE 1: Biocatalytic Desulfurization Activity of Trans¬ formed Mutants EXAMPLE 2: DNA SEQUENCING OF A DESULFURIZATION ACTIVE BIOCATALYST BY THE DIDEOXY METHOD FROM PLASMID PTOXI-1 Materials Bacterial εtrainε and plasmids Plaεmid pTOXI-1 waε used aε the original source of DNA for sequencing. Escherichia coli strain JM109 was used as a host for subcloning and plasmid maintenance. Plasmidε pUClδ and pUC19 were purchaεed from Bethesda Research Laboratories (Bethesda, MD) . Enzymes and Reagents Restriction endonucleaseε were purchased from Bethesda Reεearch Laboratorieε (BRL) and New England Bio- labε (Beverly, MA) . T4 ligase was purchased from BRL. A Sequenase Version 2.0 DNA sequencing kit was purchased from United States Biochemical Corporation (Cleveland, OH) . All enzymes and kits were uεed in accordance with manufacturer'ε recommendationε. Growth Media and conditionε E. coli εtrain JM109 harboring plaεmidε waε grown in L-broth (Difco) containing 100 μg/ml ampicillin. Tranε- formantε were εelected on L-plates εupplemented with 1.5% agar and containing 100 μg/ml ampicillin. E. coli εtrains were grown at 37°C. Methods Plasmid DNA preparation from E. coli Plasmid DNA was prepared from E. coli via lysis by SDS (Maniatis, et al. ) . The DNA was further purified through a polyethylene glycol precipitation before use in sequencing reactions. Plasmid Subcloning The following εubcloneε of pTOXI-1 were generated by εtandard techniqueε to aid in DNA εequencing: a) pMELV-1 (Figure 5) waε derived by iεolating the 6.7kb Hinddlll/Ndel fragment from pTOXI-1 (εhown in Figure 4) and ligating it to pUC-18 cut with Hindlll/Ndel. JM109 cellε harboring pMELV-l were identified by plaεmid iεo- lation and restriction endonuclease analysis (Maniatis, et al^) . b) pSMELV-lA (Figure 6) contains the 1.6kb Sphl/Xhol fragment of pMELV-l εubcloned into pUC-18. c) pSMELV-2A (Figure 6) containε the 0.7kb BamHI/SacI fragment of pMELV-l εubcloned into pUC-18. d) pSMELV-3A (Figure 6) containε the 3.5kb Sacl/Xhol fragment of pMELV-l εubcloned into pUC-18. e) pSMELV-4A (Figure 6) contaiήε the 1.5kb SphI/BamHI fragment of pMELV-l εubcloned into pUC-18. Dideoxy Sequencing from Plaεmid DNA a) Denaturation. Prior to sequencing reactions, plasmid DNA must be denatured. This waε accompliεhed by treatment with NaOH. The denatured DNA iε then recovered by addition of εalt and EtOH precipitation. Preferably, 2-5 μg of denatured plasmid DNA is used in each sequencing reaction. See manufacturer's recommendations with Se¬ quenase Version 2.0 DNA εequencing kit (United Stateε Biochemical Corporation) . b) Dideoxy εequencing. Chain termination dideoxy sequencing with Sequenase 2.0 was performed as described by the manufacturer (U.S. Biochemical Corporation) . Sequencing of the cluster was initiated by priming sub- Clones pMELV-lA, pMELV-2A, pMELV-3A, pMELV-4A with the "- 40 Universal Primer" defined aε: 5'-GTTTTCCCAGTCACGAC-3• and the "Reverεe Primer" defined as: 5'-AACAGCTATGACCATG-3' . The sequence was extended by syntheεizing overlapping oligonucleotides to previouεly read εequence uεing the Gene Assembler Plus (Pharmacia, Piscataway, NJ) . The synthesized oligonucleotides were used as primerε for continuing sequence reactions. Plas¬ mid pMELV-l was used as the template for all of the re¬ maining sequenceε. DNA sequence was read from both strands of the plasmid clone to increase fidelity. EXAMPLE 3: COMPLEMENTATION CLONING OF A DESULFURIZATION ACTIVE BIOCATALYST FROM A COSMID LIBRARY; TRANSFECTION OF BIOCATALYST DNA INTO AN R. FASCIANS HOST ORGANISM Materials and Methods Bacterial strainε, media and reagents Rhodococcuε εp. Rhodococcus rhodochrous εtrain IGTS8, obtained from the Institute of Gas Technology (Chicago, IL) was used. UV1 is a mutant of IGTS8 that is unable to deεulfurize DBT, described herein. R. fascians D188-5 (Deεomer, et al.. J. Bacteriol.. 170:2401-2405. 1988) and R. rhodochrous ATCC13808 (type strain from ATCC) do not metabolize DBT. E. coli XLl-Blue (from Stratagene Cloning System, La Jolla, CA) iε recAl lac thi endAl gyrA96 hsdR17 SUPE44 relAl fF' proAB lacl^ lacZ4M15 TnlOl . E. coli CS109 iε W1485 thi εupE F ' . E. coli S17-1 iε a derivative of E. coli 294 and is recA thi pro hsdR- res- mod- [RP4-2- Tc: :Mu-Km: :Tn2] (Simon, et al. , Plaεmid vectorε for the genetic analysis and manipulation of rhizobia and other gram-negative bacteria, p. 640-659. In A. Weissbach, and H. Weissbach (eds.), Methodε in enzy ology, vol 118, Academic Preεs, Inc., Orlando, 1986). Pseudomonaε minimal salts medium (PMS) was prepared according to Giurard and Snell (Biochemical factors in growth, p. 79-111. In P. Gerhardt, R. G. E. Murray, R. N. Coεtilow, E. W. Nester, W. A. Wood, N. R. Krieg, and G. B. Phillips (eds.), Manual of methods for general bacteriol- ogy, American Society for Microbiology, Washington, DC, 1981) and contained 0.2% glycerol, 40 mM phosphate buffer (pH 6.8), 2% Hutner's mineral baεe, and 0.1% (NH 4 ) 2 S0 4 . PMS medium lacking sulfate waε prepared with chloride εalts in place of sulfate salts. Luria broth (LB) was 1% bactotryptone, 0.5% yeast extract, and 1% NaCl. All liquid medium incubationε were performed with εhaking in water bathε (New Brunεwick Scientific, Edison, NJ) . Ampicillin (50 μg/ml) and tetracycline (12.5 μg/ml) were included aε selective agentε when required. Dibenzothio- phene (DBT) was purchased from Fluka Chemical Corporation of Ronkonkoma, NY. DBT-sulfoxide was from ICN Bio- chemicals of Irvine, CA, and DBT-sulfone was obtained from Aldrich Chemical Company of Milwaukee, WI. Agaroεe waε obtained from BRL. Plaεmid vectors pLAFR5 (Keen, et al.. Gene 10.:191-197, 1988) and pRF29 (Desomer, et al.. 1988) εerved aε εourceε of the Rhodococcuε plasmid origin of replication. Cosmid library conεtruction High molecular weight DNA was isolated from IGTS8 by the method of Consevage et al, (J . Bacteriol.. 162.:138- 146, 1985), except that cell lysiε waε accompliεhed in TE (10 mM Triε-HCl, 1 mM EDTA, pH 8.0) containing lyεozyme (5 mg/ml) and SDS (2%) . The DNA waε partially digeεted with Sau3AI and fragmentε of approximately 20 kb were isolated after centrifugation through a sodium chloride gradient (Frischauf, et al.. Digestion of DNA: εize fractionation. p. 183-189. .In S. L. Berge, and A. R. Kimmel (eds.), Methods in Enzymology, vol 152, Academic Press, Inc, San Diego, CA, 1987) . These fragments were ligated into the BamHI site of pLAFR5 using standard procedureε. In vitro packaging was performed using Gigapack Pluε (Stratagene) . Packaged coεmidε were tranεduced into E. coli S17-1. DBT spray plate assay A spray plate aεεay for the identification of bac¬ teria capable of modifying dibenzothiophene (DBT) waε originally deεcribed by Kiyohara et al, (APPI. Environ. Microbiol.. 4.3:454-457, 1982) and modified by Krawiec (Bacterial deεulfurization of thiopheneε: screening tech¬ niques and some speculations regarding the biochemical and genetic baseε, p. 103-114. In G. E. Pierce (ed.), Develop- mentε in Induεtrial Microbiology, vol 31, Society for Induεtrial Microbiology, Columbuε, Ohio, 1990) . The aεεay was further modified for use with R. rhodochrous IGTS8 aε followε. Cellε from individual IGTS8 colonies were trans¬ ferred to LB plates aε ε all (0.5 cm) patches and were incubated at 30°C for 24 to 36 h. Large amountε of cells from these patches were transferred onto PMS-1% agarose plateε that lacked a εource of εulfur. Theεe plateε were immediately sprayed with a 0.1% DBT solution in ethyl ether. The PMS-DBT plates were incubated at 30°C for a minimum of 18 hours and fluorescent products around the patches were detected by viewing under short-wave (254 nm) UV illumination. Sulfur bioavailability assay IGTS8 was incubated in PMS medium at 30°C for 24 to 48 h, the cells were pelleted by centrifugation, followed by two washes with sulfur-free PMS. Washed cells were inoculated into PMS that contained, aε a sole source of sulfur, a 0.2% concentration of one of the following: DBT, DBT-sulfoxide, or DBT-sulfone. The inoculum was adjusted so that the beginning absorbance at 600 nm (A 600 ) waε 0.02. The culture waε incubated at 30°C and growth was monitored at A 600 . For cultures incubated with DBT, the supernatant was viewed at various intervals under short wave UV light to check for production of fluorescent products. Plasmid iεolation and hvbridizationε Cosmid DNA (pLAFR5) waε iεolated from E. coli aε deεcribed by Ish-Horowicz and Burke fNucl. Acids Res.. 9_:2989-2998, 1981), and from Rhodococcus specieε aε des¬ cribed by Singer and Finnerty ( J . Bacteriol.. 170:638-645. 1988) . Large scale cosmid preparations were carried out according to Birnboim and Doly fNucl. Acids Reε.. 2:1413- 1423, 1979). DNA hybridization experiments were performed according to Southern (J. Molec. Biol.. £8.:503-517, 1975). DNA was labelled with 32 P-dCTP (Amersham) , uεing the ran¬ dom primer method of Feinberg and Vogelεtein (Anal. Bio- chem.. 132:266-267, 1984). UV mutageneεis of IGTS8 IGTS8 was incubated overnight in LB at 30°C and approximately 3000 colony forming units were spread onto fresh LB plates. These plates were immediately expoεed to short wave UV light (254 nm) for 5 to 20 s at a distance of 3.5 cm. Plates were incubated at 30°C for 48 h or until colonies developed. Colonies from plates exhibiting >50% cell death were assayed for their ability to meta¬ bolize or desulfurize DBT, uεing the εpray plate aεεay. Electrotransformation of Rhodococcus R. rhodochrous IGTS8 and the UV1 mutant were trans¬ formed with plasmid DNA via electroporation (Gene Pulser, Biorad Laboratorieε, Inc, Hercules, CA) . The bacteria were grown in LB for 24 to 48 h at 30°C, diluted to an A 600 of 0.15 with fresh LB, and incubated at 30°C for an ad¬ ditional 4 h. Cells were collected by centrifugation and washed four to five times with 0.3 M sucrose and finally resuεpended to ~5 x 10 9 cells/ml in 0.5 M sucrose. To an ice cold 0.2 cm electroporation cuvette (Biorad), was added 40 μl of thiε bacterial solution. The cellε were pulsed at 25 μF and 2.5 kV with the Pulse Controller at 800 ohms and were immediately diluted with 1 ml' of LB containing 0.5 M sucrose. The cells were incubated at 30°C for 1 h, plated on LB agar plates plus appropriate antibiotics, and incubated at 30°C until colonies de¬ veloped. When the plasmid carried the pRF29 Rhodococcus plasmid origin of replication, colonies were visible after 48 h. In the absence of the pRF29 origin, colonieε ap¬ peared after 4 to 5 dayε. R. faεcianε D188-5 waε tranεformed by electroporation in a εimilar manner but, due to its slower growth rate, it was incubated in LB overnight until it reached an A 600 of -2.0. The cells were washed and resuspended in distilled water inεtead of εucroεe. The Pulse Controller was set at 400 ohms and the recovery period after electroporation was in LB for 4 h before plating onto selective media. Suc¬ cessful transformation of R. fascianε D188-5 with E. coli plaεmidε required that the DNA be methylated in vitro beforehand, using the CpG methylase, SssI (New England Biolabε, Inc., Beverly, MA). Gaε chromatography and mass spectroscopy Cells were incubated overnight in LB medium at 30°C and 100 μl waε used to inoculate 50 ml of PMS minimal medium. The culture was incubated at 30°C for 4 days, washed twice with sulfur-free PMS and the pelleted cells were inoculated into 50 ml of PMS that contained 0.1% DBT aε the sole source of sulfur. These cells were incubated at 30 β C for 24 h and the supernatant was stored frozen at -20°C. For asεayε involving R. faεcianε D188-5, incu¬ bation timeε were increased 2 to 3-fold. Sample preparation and chemical analyses were per¬ formed as deεcribed (Olson, et al.. Energy & Fuels, sub- mitted, 1993) . Briefly, each sample supernatant (-50 ml) was thawed and residual insoluble material was removed by centrifugation. The cleared supernatant was acidified with HC1 to pH 1.0 and then extracted three times with 50 ml of ethyl acetate. Insoluble material from the centri- fugation step was also extracted with ethyl acetate. The ethyl acetate extracts were combined, dried over anhydrous calcium chloride, filtered, and ethyl acetate was removed by rotary evaporation. A known amount of internal stan¬ dard (octadecane in chloroform solution) was added to the sample, which was then analyzed by GC/FID (gaε chromato- graphy/flame ionization detection) and GC/FTIR/MS (gaε chromatography/Fourier transform infrared/masε spectro- metry) . In some samples, the acidic components in the ethyl acetate extract or in the post-extraction aqueouε layer were methylated by treating with an ether εolution of diazomethane. The analyεes were performed on a serially interfaced GC/FTIR/MS εyεtem aε previouεly deεcribed (Diehl, et al. , Spectroε. Int. J..- 8:43-72. 1990, Olεon and Diehl, Anal. Chem.. 51:443-448, 1987). This syεtem consiεted of the Finnegan ion trap (ITD 800) operated with the AGC on and the Nicolet 20SXB Fourier transform infrared spectrometer. Gas chromatography was conducted with a 30 u x 0.32 mm DB5 column (1.0 μm phaεe thickneεε) with a 2.0 ml/min helium carrier flow rate meaεured at 330°C. On-column injectionε were utilized for sample introduction becauεe the εulf- oxideε and εulfoneε are thermally unstable and they decom- poεe in split or splitlesε injectorε (Vignier, et al. , J. High Resol. Chromatogr. & Chro atogr. Co mun.. :661-665, 1983). The oven temperature program was as follows: 40°C injection, followed by increases in temperature at rates of 20°C/min to 80°C, 5"C/min to 200°C, 10°C/min to 330°C, and hold for 5 min. GC/FID analyseε were performed with a HP 5880A with a εimilar column and program for flow rate and oven temperature. Results Isolation of a Dεz- Mutant of R. rhodochrouε IGTS8 When cloning from a foreign bacterial genus into E. coli. not all genes are expressed nor are all protein products active. To assure that cloned desulfurization genes would be expresεed in the host cell, a mutant of R. rhodochrous IGTS8 that could no longer desulfurize DBT was isolated. Uεing thiε mutant as a cloning recipient would insure that the cellular environment waε appropriate for gene expression and protein function, thereby allowing screening for cloned desulfurization geneε by complemen¬ tation. R. rhodochrous IGTS8 was mutagenized by exposure to UV light, and 1000 εurvivorε were εcreened for the ability to produce a UV fluoreεcent product in the DBT spray plate assay. Three potential desulfurization negative mutants were identified and then re-evaluated in the sulfur bio¬ availability aεεay. Two mutants (designated UV1 and UV23) could not uεe DBT or DBT-εulfone aε εole εources of sulfur and thuε appeared to be Dsz-. When grown in the presence of DBT, mutant UV1 could not metabolize DBT to 2-HBP or to any other potential intermediate, as meaεured by GC/MS analyεiε. Therefore, strain UV1 was considered to be Dsz- and was used as the host for complementation studies to identify clones that carried desulfurization geneε. Coεmid cloning of desulfurization geneε DNA from Dsz+ source organism IGTS8 was uεed to conεtruct a library in the cosmid vector, pLAFR5. Thiε library waε tranεduced into E. coli S17-1 and plaεmidε were iεolated from approximately 25,000 colonieε. Theεe coεmidε were electroporated into R. rhodochrouε UV1, a Dεz- mutant of IGTS8, with an efficiency of -300 trans- formantε/μg DNA. Various numbers of UV1 transformants were pooled and incubated for 18 hours at 30°C, after which the cells were washed twice and reεuεpended in εulfate-free PMS. Approximately 7 x 10 8 pooled cellε were inoculated into 100 ml of PMS with DBT as the sole source of sulfur. A predicted product of the DBT desulfurization reaction is 2-HBP, which is fluorescent when exposed to UV light. Therefore, batch cultures were grown at 30°C and the supernatantε were obεerved for fluoreεcence. Approxi¬ mately 3300 UV1 transformants were screened in four sepa¬ rate batches. In one batch (representing -600 transfor - ants) a UV fluoreεcent product appeared in the εupernatant after five dayε* incubation. Individual colonies were isolated and twelve of these continued to produce a fluor¬ escent product when exposed to DBT. Attempts to recover cosmid DNA from these isolates failed, so Southern hybridizations were performed to determine if the cosmids had become integrated into the chromosome of strain UV1. Chromosomal DNA waε isolated from εeven transformants and digested with EcoRI. After agaroεe electrophoresis and blotting, the fragments were hybridized with 32 P-labelled probes derived from pLAFR5. In all transformants tested, pLAFR5 probes hybridized to a DNA fragment -20 kb in εize. Vector derived probeε did not hybridize to the control IGTS8 genome. Therefore, the desulfurization positive coεmid cloneε had apparently integrated into the chromosome of strain UV1. Since the plasmidε had integrated into the chromo¬ some, the genomic DNA connected to either side of the plasmid cloning site must represent R. rhodochrous IGTS8 sequences that were able to complement the Dsz- mutation in strain UV1. (This would be true regardlesε of whether the mode of integration waε by homologouε or illegitimate recombination.) Sequenceε were recovered that flanked the inεerted plaεmid from three deεulfurization positive tranεformantε by digeεting genomic preparationε with EcoRI or BamHI. Theεe enzymeε cut pLAFR5 once in the polylinker region so that an intact sequence of pLAFR5 could be recovered, linked to a neighboring chromosomal fragment from IGTS8. The digested DNA waε ligated to itself (at a concentration of -20 ng/μl) and was transformed into E. coli S17-1. Sixteen tetracycline reεistant colonies were obtained, seven from the BamHI digestion and nine from the EcoRI digestion. Restriction enzyme analysis revealed that all the EcoRI-rescued cloneε contained a 2.1 kb fragment of IGTS8 DNA. The BamHI-reεcued clones contained a 1.65 kb fragment from IGTS8. The 2.1 kb IGTS8 DNA from the EcoRI rescue experiment was used as a template to make labelled DNA probes, which were hybridized to colony lifts of the original, intact cosmid library in E. coli. Of 5000 colonieε, 17 hybri¬ dized with the IGTS8 probeε. Cosmid DNA was isolated from each clone and transformed into strain UV1. Three of the seventeen DNA preparations complemented the Dεz- pheno¬ type. A restriction map for this region was constructed, using EcoRI and Hindlll. Probes from the 2.1 kb IGTS8 DNA hybridized to the 4.5 kb EcoRI fragment. All cosmid cloneε that conferred the Dεz+ phenotype contained the entire 4.5 kb EcoRI fragment and portionε of the 4.5 kb EcoRI-Hindlll and 18 kb EcoRI fragmentε. These resultε indicated that the deεulfurization genes lay within a 15 kb region. Subcloning the desulfurization genes The 4.5 kb EcoRI and the 4.5 kb EcoRI-Hindlll frag¬ ments were subcloned into pLAFR5, but neither fragment complemented the Dsz- mutation of εtrain UVl. The 9.0 kb EcoRI fragment from GE1-H, the 15.0 kb EcoRI-Hindlll fragment from GE1-C, and the 18 kb EcoRI fragment from GE1-K were subcloned into pLAFR5 to yield the plasmidε pSAD60-28, pSAD48-12, and pSAD56-6, respectively. When transformed into UVl, all three produced UV fluorescent products from DBT in the spray plate assay, consistent with the localization of the Dsz+ phenotype aε determined by reεtriction mapping. Conεtruction of additional εub- cloneε from this region narrowed the location of the relevant genes to a 6.5 kb BstBI fragment. Nature of the mutation in strain UVl Genomic blots of EcoRI digested IGTS8 and UVl DNA were hybridized with probes produced from the 2.1 kb EcoRI-reεcued fragment of IGTS8. No hybridization was detected to UVl DNA, indicating that the UVl mutation iε a large deletion and not a εimple point mutation. A Rhodococcus plaεmid origin of replication increaεes tranεformation of UVl Electroporation of UVl with pSAD48-12 typically reεulted in a low tranεformation efficiency (-550/μg DNA) and only about 50% of the tranεformantε exhibited the Dεz+ phenotype (preεumably becauεe DNA had been lost or re¬ arranged during recombination with the chromoεome) . To improve the tranεformation efficiency, a 4.5 kb Hindlll fragment from pRF29 waε cloned into the Hindlll εite of pSAD48-12, reεulting in pSAD74-12. This 4.5 kb fragment contains a Rhodococcus plasmid origin of replication, which allowed pSAD74-12 to replicate as a plaεmid in εtrain UVl. Thiε clone tranεformed UVl with an efficiency of greater than 10 4 tranεformants/μg DNA. Nearly 100% of these tranεformantε exhibited the Dεz+ phenotype. Unfor¬ tunately, the yield of plaεmid prepared directly from UVl waε εo poor that DNA from minipreparationε could not be viεualized on agarose gelε. However, plaεmid isolated from UVl could be used to transform E. coli S17-1, from which large amountε of the plaεmid were prepared. The Dεz+ phenotype is not expreεεed in E. coli S17-1 E. coli S17-1 waε transformed with pSAD48-12 and desulfurization activity was measured with the spray plate assay. No positive colonies were identified. It waε poεεible that the E. coli polymeraεe could not recognize the IGTS8 promoter(s) in pSAD48-12, so the IGTS8 DNA waε placed under control of the E. coli lac promoter. The 15 kb EcoRI-Hindlll IGTS8 fragment from pSAD48-12 waε sub- cloned into the pBluescript vectors, SK * and KS " , so that the IGTS8 fragment was cloned in both orientations with respect to the lac promoter. Neither clone expresεed the Dεz+ phenotype in E. coli XLl-Blue. It is not yet known whether this stems from poor transcription or translation of the cloned genes or whether the overproduced proteins are inactive in E. coli S17-1. The Dsz+ gene or genes are expreεεed in R. faεcianε Since the cloned geneε were either not expreεεed or produced inactive proteins in E. coli, efforts were initi- ated to expresε the geneε in other Rhodococcuε species. R. fascianε D188-5 exhibited no deεulfurization in the DBT spray plate assay or in the sulfur bioavailability assay. Initial attempts to transform R. fascianε with the deεul¬ furization positive plaεmid, pSAD74-12 were unsucceεsful. Other Rhodococcus specieε are known to have endogenous restriction syεtemε that cleave DNA at Sail-like restric¬ tion sites. Since pSAD74-12 contained multiple Sail recognition sequenceε, CpG ethylaεe, Ssεl, waε used to methylate pSAD74-12 in vitro. With methylated pSAD74-12 DNA, tranεformantε of R. faεcianε D188-5 were obtained with an efficiency of about 7 x 10 3 tranεformantε/μg DNA. Theεe tranεformantε diεplayed the Dεz+ phenotype in the εpray plate assay and GC analysiε of liquid medium εuper- natant revealed the formation of 2-HBP from DBT. Effortε to tranεform pSAD74-12 into a second specieε, R. rhodochrous ATCC13808 were ineffective, despite the use of unmethylated or CpG-methylated plasmid. It is possible that the electroporation conditions for ATCC13808 were not optimal, though a wide range of conditions was tested. It seems more likely that ATCC13808 has a restriction system that is not inhibited by CpG methylation. 2-HBP is the major desulfurization product The predominant metabolite produced from DBT by R_j_ rhodochrous IGTS8 is 2-HBP, with small amounts of 2'- hydroxybiphenyl-2-sulfinic acid (DBT-sultine) and 2'- hydroxybiphenyl-2-εulfonic acid (DBT-εultone) alεo identi¬ fied by GC/MS analysis (Olson, et al. , Energy & Fuels in press, 1993) . These products were alεo produced by IGTS8 in thiε work (Table 2) . Neither R. fascians D188-5 nor R. rhodochrous Dεz- mutant UVl produced these products from DBT. However, when R. fascians D188-5 was transformed with plasmid pSAD74-12 and when the R. rhodochrous UVl mutant was tranεformed with plaεmid pSAD104-10, theεe bacteria produced products from DBT that were identical to those identified for R. rhodochrouε IGTS8 (Table 2) . In particular, 2-HBP waε produced in large quantitieε, indi¬ cating that carbon-sulfur bond εpecific desulfurization of DBT waε mediated by products of genes cloned from IGTS8. One subclone, pSAD90-ll, carried a DNA fragment that was supposedly identical to that cloned into pSAD104-10, but the two plasmidε differed in the reεultε they produced when introduced into R. rhodococcuε UVl. In the plate assay, the surface film of DBT disappeared from the vicin¬ ity of colonies that contained pSAD104-10, producing a clear zone, and a fluorescent halo appeared around those colonieε. On the other hand, when cellε contained pSAD90- 11, no fluoreεcent productε were produced but a zone of DBT clearing did form around each colony. GC/MS analysis showed that no 2-HBP was produced by cells containing pSAD90-ll, but that a significant amount of DBT-sultone did accumulate (Table 2) . The εultone does not accumulate in the parent strain, UVl (data not shown) . These obser- vations imply that when the 9.0 kb EcoRI fragment was subcloned into pSAD90-ll the DNA was damaged so as to inactivate the gene(s) encoding .the enzyme(s) that convert the sultone to 2-HBP. Thiε εuggeεts that at least two enzymes are involved in deεulfurization and that the sultone may be an intermediate in the pathway. Thiε reεult iε conεiεtent with the kinds of metabolites de¬ tected in the original isolate, R. rhodochrous IGTS8 (Olson, et al.. 1993) . Table 2 Metabolites produced from DBT by Rhodococcus species transformed with subclones derived from R. rhodochrous IGTS8. i I 10 Products are: DBT, dibenzothiophene; DBTO, dibenzothi¬ ophene 5-oxide (sulfoxide) ; DBT0 2 , dibenzothiophene 5,5-dioxide (sulfone); DBT-sultone, 2'-hydroxybi- -44- phenyl-2-εulfonic acid (detected aε dibenz[c,e] [1,2]- oxathiin 6,6-dioxide) ; DBT-εultine, 2'-hydroxybi- phenyl-2-εulfinic acid (detected aε dibenz[c,e] [1,2]- oxathiin 6-oxide) ; dibenzothiophene εulfone; 2-HBP, 2- hydroxybiphenyl (Krawiec, pg. 103-114. In G. E. Pierce (ed.), Developmentε in Induεtrial Microbiology, vol 31, Society for Induεtrial Microbiology, Columbuε, Ohio, 1990) . b 9.0 kb EcoRI DNA fragment from IGTS8 εubcloned into pLAFR5, pluε the origin of replication from pRF29. c Mutated 9.0 kb EcoRI DNA fragment from IGTS8 εubcloned into pLAFR5, pluε the origin of replication from pRF29. d 15.0 kb EcoRI-Hindlll DNA fragment from IGTS8 εub- cloned into pLAFR5, pluε the origin of replication from pRF29. e Preεence of metaboliteε is reported in relative amounts from very large amounts (+++++) to very εmall (+) , i.e., trace amountε. IGTS8 cannot use DBT-εulfoxide aε a εulfur εource R. rhodochrouε IGTS8 was incubated in minimal medium with one of the following as the sole source of εulfur: DBT, DBT-sulfoxide, or DBT-sulfone. IGTS8 waε incapable of utilizing the εulfur εupplied by DBT-sulfoxide but grew well in the presence of DBT or DBT-sulfone. DBT-εulfoxide waε not toxic to cellε when grown in a rich medium (LB) . Therefore, either IGTS8 cannot tranεport or otherwiεe act on DBT-εulfoxide, or else DBT-sulfoxide is not a true intermediate of the desulfurization pathway. EXAMPLE 4: DNA SEQUENCING OF A 9763 NUCLEOTIDE ECORI- SAU3AI FRAGMENT CONTAINING THE GENE OR GENES FOR THE DESULFURIZATION BIOCATALYST OF IGTS8 BY THE METHOD OF SANGER ET AL. A 9763 nucleotide EcoRI-Sau3AI fragment containing the gene or genes responsible for the Dsz+ phenotype waε iεo- lated from the IGTS8 source organiεm. The DNA sequence of this fragment was determined from both strands of DNA using the dideoxy chain-termination method of Sanger et al. (1977) , DNA sequencing with chain-termination inhibitorε, 74 PROC. NATL. ACAD. SCI. USA 5463-5467, a modified T7 DNA polymerase (USB) and [α- 35 S]-dCTP (Amersham) . Deletion clones for DNA sequencing were constructed in pBluescript (Stratagene) using exonuclease III and the methodε of Henikoff (1984) , Unidirectional digestion with exonucleaεe III createε targeted breakpoints for DNA seguencing. 28 GENE 351-359. Sequences from 141 individual deletion clones were used to reconstruct the entire 9763 nucleotide fragment. Computerized sequence assembly waε performed using DNA Inspectorll (Textco, Hanover, NH) . The DNA εequence waε determined independently for each εtrand of DNA, but the entire 9763 nucleotide fragment was not completely se- quenced on both strands. The sequence determined from one strand of DNA covered 95% of the 9763 nucleotide sequence. On the other DNA strand, 96% of the εequence waε deter¬ mined. The εequence waε determined from at leaεt two independent deletion cloneε for the entire 9763 nucleotide fragment. EXAMPLE 5: FURTHER RESOLUTION OF THE SEQUENCE OF PTOXI-1 AND OPEN READING FRAMES (ORFS) ENCODED THEREIN; DSZ+ PROMOTER ENGINEERING; EXPRESSION OF THE DSZ+ PHENOTYPE IN A HETEROLOGOUS HOST ORGANISM; MAXICELL ANALYSIS OF DESULFURIZATION GENE EXPRESSION PRODUCTS Organization of the deεulfurization cluεter Sequencing of pTOXI-1, the results of which are set forth below in the Sequence Listing, predicted three nearly contiguous open reading frameε (ORFs) on one strand of the clone (Figure 7) . The sizes of each ORF are predicated as 1359 baεeε (bpε 786-2144) for ORF 1, 1095 baεes (bps 2144- 3238) for ORF 2 and 1251 baεes (bps 3252-4502) for ORF 3. Subclone analysiε deεcribed below haε revealed that ORFs 1, 2 and 3 are required for the converεion of DBT to 2-HBP and that all of the genes encoded by theεe ORFε are transcribed on a εingle transcript aε an operon. All subclones des¬ cribed below are maintained in E. coli - Rhodococcus shut¬ tle vector pRR-6. Activity of each subclone was determined by growing transformantε of Dsz- strain CPE-648 in a rich media (RM) for 48 hours. 1 ml of the culture was used to inoculate 25 ml BSM supplemented with greater than 100 μM DBT or DBT-sulfone. Cultures were asεayed for deεulfuri¬ zation productε after 48 - 120 hourε. A diagram of each of the subcloned fragments is shown in Figure 8. In subεequent studieε, the subcloneε were grown in rich media with chloramphenicol, then croεεed into BSM supplemented with 100 μM of either DBT or DBT-εulfone. Cultureε were εhaken at 30°C for 2-5 dayε and aεεayed for desulfurization products by HPLC. A. pENOK-1: A subclone was constructed which containε the 4.0 kb SphI fragment of pTOXI-1. Thiε fragment εpans ORFs 1 and 2 but truncateε ORF 3. Analyεiε of pENOK-1 containing transformants revealed the production of no products when incubated with DBT. However these trans- formants were capable of producing 2-HBP from DBT-sulfone. B. pENOK-2: A suclone which contains the 3.6 kb Sad fragment of pTOXI-1 was constructed. This fragment con¬ tains ORFs 2 and 3 but truncates ORF 1. Analysiε of pENOK- 2 tranεformantε revealed no production of any desulfuri- zation productε from either DBT or DBT-εulfone. The lack of any activity detectable from either ORFε 2 or 3 εuggests that the ORFs are arranged aε an operon with tranεcription mediated from a εingle upεtream promoter. Preεumable, thiε promoter haε been removed in thiε subclone. C. pENOK-3: A 1.1 kb Xhol deletion mutation of pTOXI-1 was constructed. Both ORFs 1 and 2 are truncated. ORF 3 remainε intact. Tranεformantε harboring pENOK-3 εhow production of DBT-εulfone from DBT. No production of 2-HBP iε detected from either DBT or DBT-εulfone. It εhould alεo be noted that at the nucleotide level, a deletion of thiε type would not result in a polar mutation. The εequence predictε an in-frame splicing of ORFs 1 and 2 which would produce a hybrid protein that is presumably inactive. However, by avoiding stop codons, the putative single mRNA transcript remainε protected by riboεomeε allowing for translation of ORF 3. The ability of the ORF-3 product to produce DBT-sulfone from DBT demonstrates that DBT-sulfone is a true intermediate in the carbon-sulfur bond specific biocatalytic desulfurization pathway of IGTS8. D. pENOK-11: The 3.4 kb Ncol fragment from pTOXI-l was subcloned into a unique Ncol site of pRR-6. This fragment containε all of ORFε 2 and 3 but truncateε the 5' end of ORF1. Transformants with pENOK-11 demonstrated no desulfu- rizing-εpecific enzymatic activity towardε DBT or DBT- εulfone. This indicates essential coding regions bordering thiε fragment. This is consistent with the predication that the entire cluster is expresεed on a εingle transcript as discussed for subclone pENOK-2. Again, the promoter for gene transcription is not present in this subclone. Sub- clone pENOK-13 (below) corroborates this prediction. E. pENOK-13: A subclone of pTOXI-1 was conεtructed which had a 2.6 kb Sphl-Xhol deletion. Thiε εubclone only con¬ tainε an intact ORF 3. ORF 1 iε loεt completely and ORF 2 is truncated. This subclone showed no deεulfurizing-εpeci- fie enzymatic activity towards DBT or DBT-sulfone. This result should be compared with the phenotype of pENOK-3 which demonstrated production of DBT-sulfone from DBT. Because pENOK-13 differs from pENOK-3 by the additional deletion of the smaller Sphl/Xhol fragment, this would indicate an element in the 1.6 kb Sphl/Xhol fragment which iε eεsential for gene expreεεion. Becauεe εequencing haε revealed no significant ORF's contained in thiε region, it is postulated that a promoter element may be present in this region. F. pENOK-16: A subclone of pTOXI-1 was designed which eliminates nearly all unnecessary sequences from the desul¬ furization cluster. This construct contains the 4 kb BstBI-SnaBI which presumably contains all essential se¬ quence for complete deεulfurization in that in containε all of ORFε 1, 2 and 3 aε well aε 234 bases of upstream se- quence. The 3' SnaBI site lies 80 base pairs beyond the termination of ORF 3. CPE-648 harboring this plaεmid waε capable of converting DBT and DBT-εulfone to 2-HBP. pENOK- 16 thuε represents the smalleεt amount of the cluster yet observed which demonstrates the complete desulfurization phenotype. G. pENOK-18: This subclone contains a Nsil-Bfal fragment of pTOXI-1. The Nsil εite iε 23 bp downstream of the predicted εtart εite of ORF 1. CPE-648 harboring thiε subclone lacks desulfurization activity on both DBT and DBT-sulfone. Thiε εubclone moεt likely eliminateε the promoter region and truncateε the firεt structural gene. H. pENOK-Nεi: To help further elucidate the start site of ORF 1, a εubclone waε made in which a 4 bp deletion iε introduced at the unique Nεil εite which iε 23 bp down¬ stream of the predicted start site of ORF1. The mutation was generated by cutting with Nsil and blunting the ends with T4 DNA Polymeraεe. If the Nεil εite iε within the first structural gene this frameshift mutation would cause an early stop signal in ORF 1. Transformantε of pENOK-Nsi were capable of producing DBT-sulfone from DBT. However, no production of 2-HBP was detected indicating that the mutation had disrupted an esεential structural gene. In subεequent εtudieε, due to the clear expression of the ORF-3 encoded oxidase, in this clone, it was conεidered likely that the ORF-2 product would alεo be expreεεed. Accordingly, ORF-2 alone iε incapable of further metabolism of DBT-sulfone. I. pENOK-19: A subclone of pTOXI-1 was constructed which containε a deletion from the NotI εite, which is in the earlier part of ORF 2, to the SnaBI which iε after ORF 3. Thiε εubclone εhould demonεtrate the activity of ORF 1 alone. CPE648 transformants harboring thiε subclone dis¬ played no enzymatic activity towards DBT or DBT-sulfone. The results of pENOK-Nsi and pENOK-19, taken together, suggeεt that the ORF-I and ORF-2 products must be simul¬ taneously expressed in order to further metabolize DBT-sul¬ fone. J. pENOK-20: In order to evaluate the function of ORFε 2 and 3 εeparately from ORF 1, DNA εpanning ORFε 2 and 3 was amplified by the Polymeraεe Chain Reaction (PCR) . Primerε RAP-1 (5'-GCGAATTCCGCACCGAGTACC-3' , bpε 2062-2082) and RAP- 2 (5'-ATCCATATGCGCACTACGAATCC-3' bpε 4908-4886) were εyn- thesized with the Applied Biosyεtems 392 DNA/RNA Synthes- izer. Nucleotideε in bold were altered from the template εequence in order to create reεtriction sites for subclon¬ ing; thuε primer RAP-1 containε an EcoRI εite, and primer RAP-2 containε an Ndel εite. Amplification waε carried out with the GeneAmp Kit (Perkin Elmer Cetuε) which utilizeε the Taq polymerase and the Perkin Elmer Cetuε 9600 Thermo- cycler. Parameterε were as follows: Template: pMELV-l Plasmid DNA 0.2 or 2.0 ng Amplification yielded the predicted 2846 bp fragment. In order to express the amplified fragment harboring ORFs 2 and 3, it was ligated to the Xbal/EcoRI fragment of the chloramphenicol resistance gene promoter from Rhodococcus fascianε (Deεomer et al. : Molecular Microbiology (1992) 6 (16), 2377-2385) to give plaεmid pOTTO-l. Ultimately, a blunt end ligation waε used for the subcloning of the amplified product due to the fact that ligation using the engineered restriction sites was unsuccessful. This fusion waε ligated to εhuttle-vector pRR-6 to produce plaεmid pENOK-20. CPE648 transformants of pENOK-20 were grown in the presence of DBT and 25 μg/ml chloramphenicol for pro¬ moter induction. All transformantε converted DBT to DBT- sulfone presumably through the activity of the ORF 3 as demonstrated in subclone pENOK-3. The inability to further procesε DBT-εulfone with the preεence of ORF 2 εuggeεts that the product of ORF 2 alone is incapable of using DBT- sulfone aε a εubεtrate. Thiε iε conεiεtant with reεultε obtained from pENOK-Nε_i, and εuggeεtε that ORF-2 alone iε incapable of uεing DBT-sulfone as a εubstrate. Asεignment of Gene Products of ORFs 1. 2 and 3 Based on the foregoing subclone analyseε, functions have been tentatively asεigned to each of the ORFs present within the pTOXI-1 sequence. ORF 3 can be identified as responsible for an oxidase capable of conversion of DBT to DBT-εulfone. Subclone pENOK-3 demonεtrateε this activity very clearly. ORFs 1 and 2 appear to be responsible for conversion of DBT-sulfone to 2-HBP. This aryl sulfataεe activity iε evidenced in subclone pENOK-1. However sub¬ cloneε pENOK-19 and pENOK-20 indicate that neither ORF 1 or ORF 2 alone iε capable of any converεion of the inter¬ mediate DBT-εulfone. Thiε εuggestε that the protein pro- ductε of ORFε 1 and 2 work together to cleave both of the carbon-sulfur bonds. Presumably, this is achieved through a heterodimer arrangement of the proteinε, or through a regulatory function of one protein on the other. The reεultε of paralell inveεtigationε, preεented in Example 3, suggested that ORF-1 encodes an enzyme that converts DBT— sulfone to DBT-sultone. Lengthy incubations of CPE-648 harboring pENOK-19 (intact native promoter and ORF-I) have shown neither the depletion of DBT-εulfone nor the pro¬ duction of any new productε. Thiε iε contrary to indi- cationε derived from Example 3. Alternative Promoter Screening Increaεing the specific activity of desulfurization is a significant objective of the studies described herein. One approach to accomplishing this goal is to replace the original promoter with one that can produce both higher and constitutive expression of the desulfurization gene clus¬ ter. Because there are εo few reported and characterized Rhodococcuε promoterε. random genomic librarieε have been prepared and εcreened for promoter activity in two εystems. In one, the reporter is the chloramphenicol resiεtance gene uεed in the above-discusεed plaεmid conεtructionε. In the other, the deεulfurization cluεter itself is used as a reporter. Promoter Screening Example A. Chloramphenicol Resiεtance Reporter. As also described below, partially digested Rhodo¬ coccus genomic DNA has been cloned upstream of a promo- terleεε chloramphenicol reεistance gene. The resulting libraries were then transformed into Rhodococcus which are subjected to chloramphenicol selection. Four apparent promoter elements were rescued by pRHODOPRO-2, although plasmid could be isolated from only one of these, possibly due to vector instability. The εtable plaεmid RP2-2A haε been εubjected to sequence analysis. Technical problems have been observed with restriction enzyme treatment of the Nari cloning εite uεed in these vectors. Unfortunately, the Nari enzyme demonstrates severe site-selectivity and does not appear to digest the vector well. New vectors have been constructed in order to alleviate this problem, although a lack of convenient and unique restriction εiteε εlowed the progress of these studies. A recent observation on the Rhodococcus replication origin will aid in con¬ structing a more effective promoter probe, as discuεεed below. Recently, the 1.4kb Bglllfragment waε removed from pRR-6, and the endε were blunted and religated to produce pRR-12 (Figure 9) , which containε no Bglll sites. Desomer et al. (Molecular Microbiology (1992) 6 (16) , 2377-2385) reported that thiε region was needed for plasmid repli¬ cation. Thus, it was surprising that this construct was capable of producing Cm r transformants, indicating that this region was not essential for plasmid replication in the strain of organisms used for the preεent εtudieε. Thiε observation forms the conceptual basiε for conεtruction of a vector that will utilize a synthesized Bglll site for cloning the random genomic fragmentε. Bglll accepts DNA digested by Sau3A. an effective and frequent cutter of IGTS8 DNA. These constructε are expected to allow for the production of better, more repreεentative random genomic librarieε. Pro oter Screening Example B: Deεulfurization Cluεter Reporter. Vector pKAMI has been uεed aε a second direct "shot— gun" approach to finding a suitable alternative promoter (Figure 10) . An Ndel site was engineered upεtream of the promoterless Dsz cluster to serve aε the εite of inεertion of random genomic DNA (from strains GPE-362, CPE-648 and IGTS8) fractionated by Ndel and the compatible 4bp cutters Msel and Bfal. Originally, this ligation mixture was directly transformed into GPE-362 cells, which were then used en masse to inoculate 250 ml BSM + DBT. These efforts were undertaken with the goal of amplifying a superior Dsz+ εtrain due to itε ability to utilize DBT aε the sole source of sulfur. To date, 14 transformations of this type have been done. Of these, all but 2 have resulted in producing Dsz+ cultureε. Eleven individual cloneε have been iεolated and characterized. Theεe are capable of low-level (0.6 - 1.0 mg/L 2-HBP/OD 600 /hr) , conεtitutive expreεεion of the desulfurization trait. Restriction analysis of plasmids iεolated from these eleven has revealed that all but one (KB4-3) are simple rearrangements of the pKAMI backbone resulting in gratuitouε expreεεion from vector borne pro- moterε. Many of the reεcued plaεmidε show identical re¬ striction patterns although originating from separate ligationε, εuggeεting an inherent vector inεtability. It appears as if, with this type of selection, rearrangements of pKAMI that utilize a vector promoter εequence are εtron- gly selected. The above-deεcribed εelection procedure haε thuε given way to a promoter screen geared to minimize the plasmid rearrangement. In this procedure, the pKAMI/genomic li¬ brary is first amplified in E. coli. then the individual JM109 colonies are pooled together. The plasmids are extracted, and used to transform Dsz- strain GPE-362. Instead of using en masεe enrichment, the GPE362 transfor- mations are plated to Rich Media + chloramphenicol for selection of plaεmid containing cellε. Resulting colonies are replica-plated to BSM agarose + DBT plateε, then checked for deεulfurizatton activity by UV fluoreεcence production. Over 7,000 GPE-362 tranεformantε have been εcreened in this fashion. Thirty-εix have been iεolated from theεe which produce UV fluorescence on BSM + DBT plates. Current efforts focus on the identification and characterization of the engineered plasmids borne by these 36 transformants. Alternative Promotor Engineering The close physical arrangement of the three ORFs of pTOXI-1 does not provide sufficient space for promoterε for either ORFs 2 or 3. This fact, coupled with the results of the subclone analysis in which intact ORFs 2 and 3 provided no activity (see pENOK-2, pENOK-11, and pENOK-13) , sug¬ gested that this cluster of geneε iε organized aε an operon with only one promoter for expression of the three genes. Given that the desulfurization trait of IGTS8 is represεed by sulfate (Kilbane and Bielaga, Final Report D.O.E. Con¬ tract No. DE-AC22-88PC8891 (1991), it is posεible that the operon promoter iε tightly controlled by sulfur levels. With the elucidation of the molecular arrangement of the desulfurization cluster, alternative promoters can be rationally engineered to eliminate the εulfur repreεεion, increaεe expreεsion of the desulfurization genes and there- by increase the specific activity of the Dsz * trait. Exampleε of potential alternative promoters include other known and described promoters such as the chloram¬ phenicol resistance gene promoter from Rhodococcus faεcians (Desomer et al. : Molecular Microbiology (1992) 6 (16), 2377-2385) , the nitrile hydratase gene promoter from Rhodo¬ coccuε rhodochrouε (Kobayaεhi, et al. : Biochimica et Bio- phyεica Acta, 1129 (1991) 23-33) , or other strong promoters isolated from Rhodococcus sp. by "shot-gun" promoter prob¬ ing. Other potential alternative promoters include thoεe from other Gram poεitive organismε εuch aε Corynebacterium. Bacilluε. Streptomyces. and the like. Promoter Engineering Example A: Expression from the chlo¬ ramphenicol resiεtance gene promoter from Rhodococcus fascians. pSBG-2 (Figure 11) . The promoterlesε desulfurization cluster was isolated from pTOXI-1 aε a 4.0 kb Dral/SnaBl fragment and ligated to a unique blunted Af ll site of pRR- 6. This ligation inserted the cluster downstream of the chloramphenicol resistance gene promoter and upstream of the resiεtance εtructural gene. Th ε, meεsenger RNA (mRNA) transcription should proceed through the Dsz gene cluster and proceed on to the resistance gene. However, original selections of transformantε on chloramphenicol did not yield tranεformantε, suggesting poor transcriptional read- through. Dsz+ transformantε harboring the plaεmid were selected first through sulfur bioavailability assays and secondarily on chloramphenicol plates. Unlike IGTS8, pSBG- 2 transformantε are capable of converting DBT to 2-HBP in BSM media εupplemented with 20 mM Na 2 S0 A , which demon¬ strates the removal of sulfate repreε ion by promoter replacement. Specific activity of tranεformantε waε mea¬ sured between 0.9 and 1.7 mg 2-HBP/l/OD 600 /hr for a 16 hr culture in a rich media (RM) εupplemented with 25 μg/ml chloramphenicol. pSBG-3. The Rhodococcus origin of replication was removed from pSBG-2 by elimination of the 4.0 kb Xbal fragment. Without the origin, tranεformation iε obtainable only through integration. CPE-648 tranεformantε with thiε plaεmid were selected on RM + chloramphenicol and repli¬ ca-plated onto BSM + DBT plates. Colonies were obtained which produced 2-HBP, as detected by fluorescence after 18 hr of incubation at 30«>C. Individual expreεεion Of each ORF Recently, studies have been initiated to expresε the three ORFs separately, each engineered with an alternative promoter. These studies are expected to elucidate the following: First, any potential rate limiting stepε in the deεulfurizafion proceεε will be identified and overcome. Potential polarity effects of operon expresεion, i.e. poorer expreεεion of downεtream ORFε 2 and 3, may be caus¬ ing such rate limitations. Also, given the unresolved issue of the individual functions of ORFs 1 and 2, these εtudieε are expected to demonεtrate reconstitution of DBT-εulfone to 2-HBP conversion by the separate expression of ORFs 1 and 2. All ORFs were isolated through PCR amplification and subsequent subcloning. A typical Shine-Dalgarno sequence and a unique cloning site for alternative promoters has been engineered upstream of each ORF. Stop codons in all reading frames have been engineered downstream of each ORF to prevent read-through. Additionally, convenient flankng restriction sites for mobilization of the promoter/ORF fusionε have been added to each primer. The primerε uεed for amplification of each ORF are listed below. In-frame stop codonε are marked with an aεterik (*) . Sequences identical to pTOXI-I template DNA are shown in bold. ORF1UP: Xbal 5'-GGAATTCTAGACATATGAGGAACAGACCATGACTCAACAACGACAAATGC-3 ' EcoRI Ndel Start ORF1DOWN: Stop Xbal 3 » -GTACTGTTCGGCGCAGCTGGGGACTAAGATCTTAAGC-5' Stop* Stop EcoRI ORF2UP: Bglll 5 '-GGAATTCAGATCTCATATGAGGAAACAGACCATGACAAGCCGCGTCGACC-3 ' EcoRI Ndel Start ORF2DOWN: StopBglll 3 '-CGGAGTTAGCGGTGGCTATCCTTAATCTAGACTTAAGC-5 Stop* Stop Bglll ORF3UP: Msel 5'-GGAATTCTTAACATATGAGGAAACAGACCATGACACTGTCACCTGA- EcoRI Ndel Start ORF3DOWN: Msel 3 '-GACTCCTAGACTCCGCGACTAATTCTTAAGC-5' Stop* Stop Stop EcoRI Cycling parameters were: 1 x 96©C 2.0 min 25 x 96©C 30 sec 50°C 30 sec 72°C 1.0 min Each ORF has been εuccesεfully amplified and εubcloned into pUC-19 Ndel aε EcoRI fragments. Alternative promoters will be ligated into the unique Ndel sites, and the fusions will be moved to Rhodococcus-E. coli εhuttle vector pRR-6 for expreεεion in Rhodococcuε. Heterologouε Expression of the Dsz+ Trait In order to determine whether plasmid pTOXI-1 contained all of the genetic material necesεary for the Dεz+ trait, heterologous expresεion of pTOXI-1 was attempted in Rhodo¬ coccuε faεcianε. a related organiεm which doeε not metabolize DBT (Dεz-) and in E. coli. a non-related organiεm which iε alεo Dsz-. A. Rhodococcuε faεcians (ATCC 12974) , a Dsz- strain, waε tranεformed with pTOXI-1. A εingle tranεformant demonstrated UV fluorescence on BSM + DBT plates, and further analysiε by HPLC clearly indicated production of 2-HBP when DBT waε provided as a substrate. Thus pTOXI-1 contains εufficient information to convert a heterologous Dsz- εtrain to the Dsz+ phenotype. B. E. coli strain JM109 was alεo tranεformed with pTOXI-1 and waε incubated with each of the εubεtrateε DBT and DBT- sulfone in either a minimal media (BSM) or a rich media (Luria Broth) . In no case was production of 2-HBP observed by HPLC analysiε. The inability of E. coli to express the deεulfurization geneε waε not unexpected aε gram positive genes are not universally expressible in E. coli without promoter replacement. In order to replace the promoter of the desulfurization cluεter, a 4.0 kb Dral/SnaBI fragment waε iεolated from pTOXI-1. This fragment contains all of the necessary struc¬ tural genes but lacks the promoter sequenceε. Thiε pro- moterless desulfurization cluster was ligated to E. coli expresεion vector pDR540 (Pharmacia, Piεcataway, NJ) cut with BamHI and endε made blunt with Klenow. The conεtruction fuseε the tac promoter to the deεulfurization cluεter. The tac promoter is under control of the lactose repressor and iε repreεεed in a lacl q host εuch as JM109. Expresεion from the tac promoter is inducible by the addition of isopropyl β-D- thiogalactopyranoεide (IPTG) . Transformantε of JM109 harbor- ing pDRDsz grown in Luria Broth at 30"C demonstrate the Dsz+ phenotype when incubated with DBT and induced with IPTG. A specific activity as high as 1.69 mg 2HBP/l/OD 600 /hr has been observed with pDRDsz. Activity is greatly diminished when transformants are grown at 37°C. The highest level of activ- ity has been observed at Ihr poεt induction. The above-deεcribed expression of the Dsz+ trait in both a related and non-related heterologous host indicates that pTOXI-1 carries all of the genetic information required for conversion of DBT to 2-HBP. Succesεful expreεεion in E. coli provided a workable εyεtem in which the proteins encoded by the desulfurization cluster could be identified and characterized. Total protein from Dsz+ cellε of JMI09 (pDRDsz) waε iεolated and examined on denaturing acrylamide gelε. No novel bandε could be detected with Coomassie stain. Cellular fractionation of proteinε into periplaεmic, cytosolic and membrane components were also analyzed by Coomassie εtained gelε. Again, no novel bandε were detected. Without any purification, the newly expreεsed proteinε were apparently levels too low to easily detect and resolve from background. Maxicell Analvsiε of E. coli harboring pDRDεz Proteinε encoded by genes on plasmid DNA can be specifi¬ cally radiolabeled in UV-irradiated cellε of E. coli (Sancar, et al. Journal of Bacteriology. 1979, p. 692-693) . This technique is known as Maxicell Analysis. Briefly, a recA strain of E. coli e.g. JM109 which harbors a plasmid is grown in M9CA medium (Maniatis et al. ) to a density of 2 x 10 8 cells/ml. Continuouεly εtirred cellε were then εubjected to UV exposure from a Mineralight Lamp Model UVG-254 (Ultro- vilet Productε, Inc., San Gabriel, CA) at a diεtance of 10 cm -64- for a fluence rate of 0.5 Joules-m '2 ε '1 . Cellε were expoεed for either 60, 90 or 120 seconds. The cellε were then incu¬ bated at 37°C for 16 hours after which they were then washed with M9 buffer and suspended in minimal medium lacking sul¬ fate. After 1 hour of starvation at 37°C, [ 35 S]methionine (>1000 Ci/mmol) (NEN Research Products, Boston, MA) was added at a final concentration of 5 μCi/ml and incubation was continued for 1 hour. Cells were collected by centrifugation and proteins isolated through a boiled cell procedure (Mani¬ atis, et al. Proteins were separated on an acrylamide gel. After the run, the gel was dried and subjected to autoradio- graphy for 3 days. Maxicells of JM109 harboring vector pDR540 showed only vector marker galactokinase protein. Maxicells of JM109 harboring vector pDRDsz showed the presence of three novel protein bands of sizes which correlated well with the pre¬ dicted molecular weights of the three proteinε responsible for the Dsz+ trait, as predicted by open reading frame analy¬ sis (see Table 3) . Table 3 Data obtained from Maxicell analysiε thuε indicated that the three predicted open reading frameε of pTOXI-1 encode three εtructural genes which conεtitute the deεul¬ furization phenotype. The relative intenεity of the three novel bands is reflective of both the number of methionine residues and the level of translation for each of the proteinε. Clear¬ ly, ORF-2 with only 1 Met giveε the fainteεt band. In addition to the incorporation of only a single Met reεi- due, E. coli may procesε the εingle terminal methionine, further reducing the amount of labelled protein. There¬ fore, the low intenεity of the ORF-2 band most lively does not strictly suggest a low level of protein trans¬ lation. Interestingly, the ORF furtheεt from the promoter (ORF-3) appears to be present at levels comparable to ORF-1, indicating no polar effectε in thiε operon when expressed in E. coli. It is expected that more signifi¬ cant information regarding protein levels will be ob¬ tained from a similar Maxicell analysiε of a Rhodococcuε sp. host containing plasmid pTOXI-I. Additionally, the presence of an ORF-I/ORF-2 heterodimer, postulated above, may be observable under non-denaturing conditionε. As required by 37 C.F.R. Section 1.821(f), Ap¬ plicant's Attorney hereby states that the content of the "Sequence Listing" in thiε specification in paper form and the content of the computer-readable form (diskette) of the "Sequence Listing" are the same. EQUIVALENTS Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. These and all other such equivalents are intended to be encompasεed by the follow¬ ing claimε. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: (A) NAME: Energy BioSystems Corporation (B) STREET: 3608 Research Forest Drive B-7 (C) CITY: The Woodlands (D) STATE: TX (E) COUNTRY: US (F) ZIP: 77381 (G) TELEPHONE: 713-364-6100 (H) TELEFAX: 713-364-6110 (ii) TITLE OF INVENTION: Recombinant DNA Encoding A Desulfurization Biocatalyst (iii) NUMBER OF SEQUENCES: 5 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: Hamilton, Brook, Smith and Reynolds, P.C. (B) STREET: Two Militia Drive (C) CITY: Lexington (D) STATE: Massachusetts (E) COUNTRY: U.S.A. (F) ZIP: 02173 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentin Release #1.0, Version #1.25 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: (B) FILING DATE: (C) CLASSIFICATION: (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: Brook, David E (B) REGISTRATION NUMBER: 22,592 (C) REFERENCE/DOCKET NUMBER: EBC92-03A (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: 617-861-6240 (B) TELEFAX: 617-861-9540 (2) INFORMATION FOR SEQ ID NO:l: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 5535 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 790..2151 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 3256..4506 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: GCATGCACGT CGCGCCGACG CATTTGCGCG CACGGCTCCG GGCAGTTCTC GCGGCGCTGG 60 AGGCACGGAT GGGCACCCTC AACGAACTCA CCCAAACCAC GCCGATAGCG ATCCTCGCCG 120 AAACCCTCGG CTACAGCCCT CAGACATTGG AAGCTCATGC GCGACGCATC CGGATCGACC 180 TTTGCACGCT ACGTGGCGAC GCGGCTGGAC TGACGCTGGA GGTCCGACCC GACGTGTGTG 240 GTGTAGCGCC GCTTAACGGG TGCGCACGGC GGGACATCGG CCAGCTGGCT TGCCCCTCCT 300 CCGCAGGTAG TCGACCACCC CTTCCCGCAG CGGTCGGAGG TGATCGACCG TTAGGGTCAT 360 TTGCTCGCAG ATCGGCTGAT GTTGCCGATC GACGTGGTCG ACGGGACACG CTCGCGATTG 420 GCATGGCGTC CGGTGCATAC ACGACGATCT AACCAGATCG ACGGTTTTGA GCGTCGGTCA 480 ACGTCGACTC GATGCGCCGT GCGAGTGAGA TCCTTTGTGG TGCTTGGCTA TTGACCTCGA 540 CAAGGATAGA GATTCGAAGG ACCTCGGATC GACCCAAATG CGGACGGCCG GCAGCGGCGA 600 AGGCGGCCAA GTCATCGGCA CCGTCACCGT CACCTTGACC CGACGTGCCC CGTGGTTCAA 660 GGCCTGAATT TGGCTGGTGG AGCATTGAAA TCAGGTGAAG TTTAACGGTG GGCACACCCC 720 GGGGGTGGGG GTGAGACTGC TTAGCGACAG GAATCTAGCC ATGATTGACA TTTAAAGGAC 780 GCATACGCG ATG ACT CAA CAA CGA CAA ATG CAT CTG GCC GGT TTC TTC 828 Met Thr Gin Gin Arg Gin Met His Leu Ala Gly Phe Phe 1 5 10 TCG GCC GGC AAT GTG ACT CAT GCA CAT GGG GCG TGG CGG CAC ACG GAC 876 Ser Ala Gly Asn Val Thr His Ala His Gly Ala Trp Arg His Thr Asp 15 20 25 GCG TCG AAT GAC TTT CTG TCG GGG AAG TAC TAC CAA CAC ATC 'GCC CGT 924 Ala Ser Asn Asp Phe Leu Ser Gly Lys Tyr Tyr Gin His lie Ala Arg 30 35 40 45 ACT CTG GAG CGC GGC AAG TTC GAT CTG TTG TTT CTG CCT GAC GGG TTG 972 Thr Leu Glu Arg Gly Lys Phe Asp Leu Leu Phe Leu Pro Asp Gly Leu 50 55 60 GCC GTC GAG GAC AGC TAC GGG GAC AAC CTG GAC ACC GGT GTC GGC CTG 1020 Ala Val Glu Asp Ser Tyr Gly Asp Asn Leu Asp Thr Gly Val Gly Leu 65 70 75 GGC GGG CAG GGT GCA GTC GCC TTG GAG CCG GCC AGT GTG GTC GCA ACC 1068 Gly Gly Gin Gly Ala Val Ala Leu Glu Pro Ala Ser Val Val Ala Thr 80 85 90 ATG GCC GCG GTG ACC GAG CAC CTG GGT CTT GGG GCA ACC ATT TCG GCG 1116 Met Ala Ala Val Thr Glu His Leu Gly Leu Gly Ala Thr lie Ser Ala 95 100 105 ACC TAC TAT CCC CCG TAT CAC GTT GCT CGG GTG TTC GCG ACG CTC GAT 1164 Thr Tyr Tyr Pro Pro Tyr His Val Ala Arg Val Phe Ala Thr Leu Asp 110 115 120 125 CAG TTG TCA GGG GGT CGG GTG TCC TGG AAC GTC GTC ACC TCG CTC AAC 1.212 Gin Leu Ser Gly Gly Arg Val Ser Trp Asn Val Val Thr Ser Leu Asn 130 135 140 GAC GCT GAA GCG CGC AAC TTC GGC ATT AAT CAG CAT CTG GAA CAC GAC 1260 Asp Ala Glu Ala Arg Asn Phe Gly lie Asn Gin His Leu Glu His Asp 145 150 155 GCC CGC TAT GAC CGC GCC GAT GAG TTC TTG GAA GCG GTC AAG AAA CTC 1308 Ala Arg Tyr Asp Arg Ala Asp Glu Phe Leu Glu Ala Val Lys Lys Leu 160 165 170 TGG AAC AGC TGG GAC GAG GAC GCC CTC GTG CTG GAC AAG GCG GCC GGC 1356 Trp Asn Ser Trp Asp Glu Asp Ala Leu Val Leu Asp Lys Ala Ala Gly 175 180 185 GTG TTC GCC GAT CCC GCG AAG GTG CAC TAC GTC GAT CAC CAC GGG GAG 1404 Val Phe Ala Asp Pro Ala Lys Val His Tyr Val Asp His His Gly Glu 190 195 200 205 TGG CTG AAT GTG CGC GGA CCT CTG CAG GTA CCG CGT TCA CCT CAG GGT 1452 Trp Leu Asn Val Arg Gly Pro Leu Gin Val Pro Arg Ser Pro Gin Gly 210 215 220 GAG CCG GTG ATC CTG CAG GCC GGC CTG TCG CCC CGG GGT CGG CGC TTC 1500 Glu Pro Val lie Leu Gin Ala Gly Leu Ser Pro Arg Gly Arg Arg Phe 225 230 235 GCC GGG AAG TGG GCC GAG GCC GTC TTC AGT CTT GCA CCC AAC CTC GAG 1548 Ala Gly Lys Trp Ala Glu Ala Val Phe Ser Leu Ala Pro Asn Leu Glu 240 245 250 GTG ATG CAG GCC ACC TAC CAG GGC ATC AAA GCC GAG GTC GAC GCT GCG 1596 Val Met Gin Ala Thr Tyr Gin Gly He Lys Ala Glu Val Asp Ala Ala 255 260 265 GGG CGC GAT CCC GAT CAG ACG AAA ATC TTC ACC GCC GTG ATG CCG GTA 1644 Gly Arg Asp Pro Asp Gin Thr Lys He Phe Thr Ala Val Met Pro Val 270 275 280 285 CTC GGC GAA AGC CAG GCG GTG GCA CAG GAA CGA CTG GAA TAT CTC AAC 1692 Leu Gly Glu Ser Gin Ala Val Ala Gin Glu Arg Leu Glu Tyr Leu Asn 290 295 300 AGT CTG GTC CAT CCG GAA GTG GGA CTG TCG ACG CTA TCC AGT CAC ACC 1740 Ser Leu Val His Pro Glu Val Gly Leu Ser Thr Leu Ser Ser His Thr 305 310 315 GGC ATC AAC CTG GCG GCG TAC CCT CTC GAC ACT CCG ATC AAG GAC ATC 1788 Gly He Asn Leu Ala Ala Tyr Pro Leu Asp Thr Pro He Lys Asp He 320 325 330 CTG CGG GAT CTG CAG GAT CGG AAT GTC CCG ACG CAA CTG CAC ATG TTC 1836 Leu Arg Asp Leu Gin Asp Arg Asn Val Pro Thr Gin Leu His Met Phe 335 340 345 GCC GCC GCA ACG CAC AGC GAA GAG CTC ACG CTG GCG GAA ATG GGT CGG 1884 Ala Ala Ala Thr His Ser Glu Glu Leu Thr Leu Ala Glu Met Gly Arg 350 355 360 365 CGC TAT GGA ACC AAC GTG GGG TTC GTT CCT CAG TGG GCC GGT ACC GGG 1932 Arg Tyr Gly Thr Asn Val Gly Phe Val Pro Gin Trp Ala Gly Thr Gly 370 375 380 GAG CAG ATC GCT GAC GAG CTG ATC CGC CAC TTC GAG GGC GGC GCC GCG 1980 Glu Gin He Ala Asp Glu Leu He Arg His Phe Glu Gly Gly Ala Ala 385 390 395 GAT GGT TTC ATC ATC TCT CCG GCC TTC CTG CCG GGC TCC TAC GAC GAG 2028 Asp Gly Phe He He Ser Pro Ala Phe Leu Pro Gly Ser Tyr Asp Glu 400 405 410 TTC GTC GAC CAG GTG GTT CCG GTT CTG CAG GAT CGC GGC TAC TTC CGC 2076 Phe Val Asp Gin Val Val Pro Val Leu Gin Asp Arg Gly Tyr Phe Arg 415 420 425 ACC GAG TAC CAG GGC AAC ACT CTG CGC GAC CAC TTG GGT CTG CGC GTA 2124 Thr Glu Tyr Gin Gly Asn Thr Leu Arg Asp His Leu Gly Leu Arg Val 430 435 440 445 CCA CAA CTG CAA GGA CAA CCT TCA TGACAAGCCG CGTCGACCCC GCAAACCCCG 2178 Pro Gin Leu Gin Gly Gin Pro Ser 450 GTTCAGAACT CGATTCCGCC ATCCGCGACA CACTGACCTA CAGCAACTGC CCGGTACCCA 2238 ACGCTCTGCT CACGGCATCG GAATCGGGCT TCCTCGACGC CGCCGGCATC GAACTCGACG 2298 TCCTCAGCGG CCAGCAGGGC ACGGTTCATT TCACCTACGA CCAGCCTGCC TACACCCGTT 2358 TTGGGGGTGA GATCCCGCCA CTGCTCAGCG AGGGGTTGCG GGCACCTGGG CGCACGCGTC 2418 TACTCGGCAT CACCCCGCTC TTGGGGCGCC AGGGCTTCTT TGTCCGCGAC GACAGCCCGA 2478 TCACAGCGGC CGCCGACCTT GCCGGACGTC GAATCGGCGT CTCGGCCTCG GCAATTCGCA 2538 TCCTGCGCGG CCAGCTGGGC GACTACCTCG AGTTGGATCC CTGGCGGCAA ACGCTGGTAG 2598 CGCTGGGCTC GTGGGAGGCG CGCGCCTTGT TGCACACCCT TGAGCACGGT GAACTGGGTG 2658 TGGACGACGT CGAGCTGGTG CCGATCAGCA GTCCTGGTGT CGATGTTCCC GCTGAGCAGC 2718 TCGAAGAATC GGCGACCGTC AAGGGTGCGG ACCTCTTTCC CGATGTCGCC CGCGGTCAGG 2778 CCGCGGTGTT GGCCAGCGGA GACGTTGACG CCCTGTACAG TTGGCTGCCC TGGGCCGGGG 2838 AGTTGCAAGC CACCGGGGCC CGCCCAGTGG TGGATCTCGG CCTCGATGAG CGCAATGCCT 2898 ACGCCAGTGT GTGGACGGTC AGCAGCGGGC TGGTTCGCCA GCGACCTGGC CTTGTTCAAC 2958 GACTGGTCGA CGCGGCCGTC GACGCCGGGC TGTGGGCACG CGATCATTCC GACGCGGTGA 3018 CCAGCCTGCA CGCCGCGAAC CTGGGCGTAT CGACCGGAGC AGTAGGCCAG GGCTTCGGCG 3078 CCGACTTCCA GCAGCGTCTG GTTCCACGCC TGGATCACGA CGCCCTCGCC CTCCTGGAGC 3138 GCACACAGCA ATTCCTGCTC ACCAACAACT TGCTGCAGGA ACCCGTCGCC CTCGATCAGT 3198 GGGCGGCTCC GGAATTTCTG AACAACAGCC TCAATCGCCA CCGATAGGAA CATCCGC 3255 ATG ACA CTG TCA CCT GAA AAG CAG CAC GTT CGA CCA CGC GAC GCC GCC 3303 Met Thr Leu Ser Pro Glu Lys Gin His Val Arg Pro Arg Asp Ala Ala 1 5 10 15 GAC AAC GAT CCC GTC GCG GTT GCC CGT GGG CTA GCC GAA AAG TGG CGA 3351 Asp Asn Asp Pro Val Ala Val Ala Arg Gly Leu Ala Glu Lys Trp Arg 20 25 30 GCC ACC GCC GTC GAG CGT GAT CGC GCC GGG GGT TCG GCA ACA GCC GAG 3399 Ala Thr Ala Val Glu Arg Asp Arg Ala Gly Gly Ser Ala Thr Ala Glu 35 40 45 CGC GAA GAC CTG CGC GCG AGC GCG CTG CTG TCG CTC CTC GTC CCG CGC 3447 Arg Glu Asp Leu Arg Ala Ser Ala Leu Leu Ser Leu Leu Val Pro Arg 50 55 60 GAA TAC GGC GGC TGG GGC GCA GAC TGG CCC ACC GCC ATC GAG GTC GTC 3495 Glu Tyr Gly Gly Trp Gly Ala Asp Trp Pro Thr Ala He Glu Val Val 65 70 75 80 CGC GAA ATC GCG GCA GCC GAT GGA TCT TTG GGA CAC CTG TTC GGA TAC 3543 Arg Glu He Ala Ala Ala Asp Gly Ser Leu Gly His Leu Phe Gly Tyr 85 90 95 CAC CTC ACC AAC GCC CCG ATG ATC GAA CTG ATC GGC TCG CAG GAA CAA 3591 His Leu Thr Asn Ala Pro Met He Glu Leu He Gly Ser Gin Glu Gin 100 105 110 GAA GAA CAC CTG TAC ACC CAG ATC GCG CAG AAC AAC TGG TGG ACC GGA 3639 Glu Glu His Leu Tyr Thr Gin He Ala Gin Asn Asn Trp Trp Thr Gly 115 120 125 AAT GCC TCC AGC GAG AAC AAC AGC CAC GTG CTG GAC TGG AAG GTC AGC 3687 Asn Ala Ser Ser Glu Asn Asn Ser His Val Leu Asp Trp Lys Val Ser 130 135 140 GCC ACC CCG ACC GAA GAC GGC GGC TAC GTG CTC AAT GGC ACG AAG CAC 3735 Ala Thr Pro Thr Glu Asp Gly Gly Tyr Val Leu Asn Gly Thr Lys His 145 150 155 160 TTC TGC AGC GGC GCC AAG GGG TCG GAC CTG CTG TTC GTG TTC GGC GTC 3783 Phe Cys Ser Gly Ala Lys Gly Ser Asp Leu Leu Phe Val Phe Gly Val 165 170 175 GTC CAG GAT GAT TCT CCG CAG CAG GGT GCG ATC ATT GCT GCC GCT ATC 3831 Val Gin Asp Asp Ser Pro Gin Gin Gly Ala He He Ala Ala Ala He 180 185 190 CCG ACA TCG CGG GCT GGC GTT ACG CCC AAC GAC GAC TGG GCC GCC ATC 3879 Pro Thr Ser Arg Ala Gly Val Thr Pro Asn Asp Asp Trp Ala Ala He 195 200 205 GGC ATG CGG CAG ACC GAC AGC GGT TCC ACG GAC TTC CAC AAC GTC AAG 3927 Gly Met Arg Gin Thr Asp Ser Gly Ser Thr Asp Phe His Asn Val Lys 210 215 220 GTC GAG CCT GAC GAA GTG CTG GGC GCG CCC AAC GCC TTC GTT CTC GCC 3975 Val Glu Pro Asp Glu Val Leu Gly Ala Pro Asn Ala Phe Val Leu Ala 225 230 235 240 TTC ATA CAA TCC GAG CGC GGC AGC CTC TTC GCG CCC ATA GCG CAA TTG 4023 Phe He Gin Ser Glu Arg Gly Ser Leu Phe Ala Pro He Ala Gin Leu 245 250 255 ATC TTC GCC AAC GTC TAT CTG GGG ATC GCG CAC GGC GCA CTC GAT GCC 4071 He Phe Ala Asn Val Tyr Leu Gly He Ala His Gly Ala Leu Asp Ala 260 265 270 GCC AGG GAG TAC ACC CGT ACC CAG GCG AGG CCC TGG ACA CCG GCC GGT 4119 Ala Arg Glu Tyr Thr Arg Thr Gin Ala Arg Pro Trp Thr Pro Ala Gly 275 280 285 ATT CAA CAG GCA ACC GAG GAT CCC TAC ACC ATC CGC TCC TAC GGT GAG 4167 He Gin Gin Ala Thr Glu Asp Pro Tyr Thr He Arg Ser Tyr Gly Glu 290 295 300 TTC ACC ATC GCA TTG CAG GGA GCT GAC GCC GCC GCC CGT GAA GCG GCC 4215 Phe Thr He Ala Leu Gin Gly Ala Asp Ala Ala Ala Arg Glu Ala Ala 305 310 315 320 CAC CTG CTG CAG ACG GTG TGG GAC AAG GGC GAC GCG CTC ACC CCC GAG 4263 His Leu Leu Gin Thr Val Trp Asp Lys Gly Asp Ala Leu Thr Pro Glu 325 330 335 GAC CGC GGC GAA CTG ATG GTG AAG GTC TCG GGA GTC AAA GCG TTG GCC 4311 Asp Arg Gly Glu Leu Met Val Lys Val Ser Gly Val Lys Ala Leu Ala 340 345 350 ACC AAC GCC GCC CTC AAC ATC AGC AGC GGC GTC TTC GAG GTG ATC GGC 4359 Thr Asn Ala Ala Leu Asn He Ser Ser Gly Val Phe Glu Val He Gly 355 360 365 GCG CGC GGA ACA CAT CCC AGG TAC GGT TTC GAC CGC TTC TGG CGC AAC 4407 Ala Arg Gly Thr His Pro Arg Tyr Gly Phe Asp Arg Phe Trp Arg Asn 370 375 380 GTG CGC ACC CAC TCC CTG CAC GAC CCG GTG TCC TAC AAG ATC GCC GAC 4455 Val Arg Thr His Ser Leu His Asp Pro Val Ser Tyr Lys He Ala Asp 385 390 395 400 GTC GGC AAG CAC ACC TTG AAC GGT CAA TAC CCG ATT CCC GGC TTC ACC 4503 Val Gly Lys His Thr Leu Asn Gly Gin Tyr Pro He Pro Gly Phe Thr 405 410 415 TCC TGAGGATCTG AGGCGCTGAT CGAGGCCGAG GCCACCGCGC GGCCGAGTCG 4556 Ser CGAATCGCCC GCCGATACTC AGCTTCTCCA TACGTACGGG TGCACACAAG GAGATATTGT 4616 CAAGACCTGT GGATGAGGGT GTTTCAGGCG ACCTCCGTTT CGCTTGATTC GTCGGGCTCA 4676 GCGGGTGAGA TGTCGATGGG TCGTTCGAGC AGCTTGCCTT TGTGGAACAC CGCGCCGGCA 4736 CGGACCAGCG CGACCAGATG GGGGGCGTTG ACCGCCGCCA GCGGGCTTGT GCGGCGTCGA 4796 TCAGCTTGTA GGCCATGGCA ATCCCGCTGC GACGTGACCC AGGGCCCTTG GTGACCTTGG 4856 TTCGCAACCG CACGGTCGCA AACGTCGATT CGATCGGATT CGTAGTGCGC AAGTGGATCC 4916 AGTGCTCGGC CGGGTACCGG TAGAACTCCA GGAGCACGTC GGCGTCGTCG ACGATCTTGG 4976 CGACCGCCTT GGGGTACTTC GCGCCGTAAT CTACCTCGAA GGCCTTGATC GCGACCTGGG 5036 CCTTGTCGAT GTCCTCGGCG TTGTAGATTT CCCGCATCGC CGCGGTCGCA CCTGGATGAG 5096 CCGACTTGGG CAGCGCAGCA AGCACATTGG CCTGCTTGTG AAACCAGCAG CGCTGTTCAC 5156 GGGTATCCGG AAACACCTCC CGCAGTGCCT TCCAGAACCC CAGCGCCCCA TCACCGACGG 5216 CCAGCACCGG GGCGGTCATC CCGCGGCGTC GGCATGAGCG CAGCAGATCA GCCCACGACT 5276 CTGTGGACTC CCGGAACCCA TCGGTGAGCG CGACGAGCTC CTTGCGGCCG TCGGCGCGGA 5336 CGCCGATCAT CACGAGCAAG CACAGCTTCT CCTGCTCCAG GCGGACATTG AGATGGATGC 5396 CGTCGACCCA TAGGTACACG AAATCGGTGC CCGAGAGATC CCGGTCGGCG AAGGCCTTCG 5456 CCTCGTCCTG CCATTGCGCG GTCAGCCGGG TGATCGTCGA GGCCGACAGC CCGGCACCAG 5516 TGCCGAGGAA CTGCTCCAA 5535 (2) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 454 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: Met Thr Gin Gin Arg Gin Met His Leu Ala Gly Phe Phe Ser Ala Gly 1 5 10 15 Asn Val Thr His Ala His Gly Ala Trp Arg His Thr Asp Ala Ser Asn 20 25 30 Asp Phe Leu Ser Gly Lys Tyr Tyr Gin His He Ala Arg Thr Leu Glu 35 40 45 Arg Gly Lys Phe Asp Leu Leu Phe Leu Pro Asp Gly Leu Ala Val Glu 50 55 60 Asp Ser Tyr Gly Asp Asn Leu Asp Thr Gly Val Gly Leu Gly Gly Gin 65 70 75 80 Gly Ala Val Ala Leu Glu Pro Ala Ser Val Val Ala Thr Met Ala Ala 85 90 95 Val Thr Glu His Leu Gly Leu Gly Ala Thr He Ser Ala Thr Tyr Tyr 100 105 HO Pro Pro Tyr His Val Ala Arg Val Phe Ala Thr Leu Asp Gin Leu Ser 115 120 125 Gly Gly Arg Val Ser Trp Asn Val Val Thr Ser Leu Asn Asp Ala Glu 130 135 140 Ala Arg Asn Phe Gly He Asn Gin His Leu Glu His Asp Ala Arg Tyr 145 150 155 160 Asp Arg Ala Asp Glu Phe Leu Glu Ala Val Lys Lys Leu Trp Asn Ser 165 170 175 Trp Asp Glu Asp Ala Leu Val Leu Asp Lys Ala Ala Gly Val Phe Ala 180 185 190 Asp Pro Ala Lys Val His Tyr Val Asp His His Gly Glu Trp Leu Asn 195 200 205 Val Arg Gly Pro Leu Gin Val Pro Arg Ser Pro Gin Gly Glu Pro Val 210 215 220 He Leu Gin Ala Gly Leu Ser Pro Arg Gly Arg Arg Phe Ala Gly Lys 225 230 235 240 Trp Ala Glu Ala Val Phe Ser Leu Ala Pro Asn Leu Glu Val Met Gin 245 250 255 Ala Thr Tyr Gin Gly He Lys Ala Glu Val Asp Ala Ala Gly Arg Asp 260 265 270 Pro Asp Gin Thr Lys He Phe Thr Ala Val Met Pro Val Leu Gly Glu 275 280 285 Ser Gin Ala Val Ala Gin Glu Arg Leu Glu Tyr Leu Asn Ser Leu Val 290 295 300 His Pro Glu Val Gly Leu Ser Thr Leu Ser Ser His Thr Gly He Asn 305 310 315 320 Leu Ala Ala Tyr Pro Leu Asp Thr Pro He Lys Asp He Leu Arg Asp 325 330 335 Leu Gin Asp Arg Asn Val Pro Thr Gin Leu His Met Phe Ala Ala Ala 340 345 350 Thr His Ser Glu Glu Leu Thr Leu Ala Glu Met Gly Arg Arg Tyr Gly 355 360 365 Thr Asn Val Gly Phe Val Pro Gin Trp Ala Gly Thr Gly Glu Gin He 370 375 380 Ala Asp Glu Leu He Arg His Phe Glu Gly Gly Ala Ala Asp Gly Phe 385 390 395 400 He He Ser Pro Ala Phe Leu Pro Gly Ser Tyr Asp Glu Phe Val Asp 405 410 415 Gin Val Val Pro Val Leu Gin Asp Arg Gly Tyr Phe Arg Thr Glu Tyr 420 425 430 Gin Gly Asn Thr Leu Arg Asp His Leu Gly Leu Arg Val Pro Gin Leu 435 440 445 Gin Gly Gin Pro Ser 450 (2) INFORMATION FOR SEQ ID NO:3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 416 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: Met Thr Leu Ser Pro Glu Lys Gin His Val Arg Pro Arg Asp Ala Ala 1 5 10 15 Asp Asn Asp Pro Val Ala Val Ala Arg Gly Leu Ala Glu Lys Trp Arg 20 25 30 Ala Thr Ala Val Glu Arg Asp Arg Ala Gly Gly Ser Ala Thr Ala Glu 35 40 45 Arg Glu Asp Leu Arg Ala Ser Ala Leu Leu Ser Leu Leu Val Pro Arg 50 55 60 Glu Tyr Gly Gly Trp Gly Ala Asp Trp Pro Thr Ala He Glu Val Val 65 70 75 80 Arg Glu He Ala Ala Ala Asp Gly Ser Leu Gly His Leu Phe Gly Tyr 85 90 95 His Leu Thr Asn Ala Pro Met He Glu Leu He Gly Ser Gin Glu Gin 100 105 110 Glu Glu His Leu Tyr Thr Gin He Ala Gin Asn Asn Trp Trp Thr Gly 115 120 125 Asn Ala Ser Ser Glu Asn Asn Ser His Val Leu Asp Trp Lys Val Ser 130 135 140 Ala Thr Pro Thr Glu Asp Gly Gly Tyr Val Leu Asn Gly Thr Lys His 145 150 155 160 Phe Cys Ser Gly Ala Lys Gly Ser Asp Leu Leu Phe Val Phe Gly Val 165 170 175 Val Gin Asp Asp Ser Pro Gin Gin Gly Ala He He Ala Ala Ala He 180 185 190 Pro Thr Ser Arg Ala Gly Val Thr Pro Asn Asp Asp Trp Ala Ala He 195 200 205 Gly Met Arg Gin Thr Asp Ser Gly Ser Thr Asp Phe His Asn Val Lys 210 215 220 Val Glu Pro Asp Glu Val Leu Gly Ala Pro Asn Ala Phe Val Leu Ala 225 230 235 240 Phe He Gin Ser Glu Arg Gly Ser Leu Phe Ala Pro He Ala Gin Leu 245 250 255 He Phe Ala Asn Val Tyr Leu Gly He Ala His Gly Ala Leu Asp Ala 260 265 270 Ala Arg Glu Tyr Thr Arg Thr Gin Ala Arg Pro Trp Thr Pro Ala Gly 275 280 285 He Gin Gin Ala Thr Glu Asp Pro Tyr Thr He Arg Ser Tyr Gly Glu 290 295 300 Phe Thr He Ala Leu Gin Gly Ala Asp Ala Ala Ala Arg Glu Ala Ala 305 310 315 320 His Leu Leu Gin Thr Val Trp Asp Lys Gly Asp Ala Leu Thr Pro Glu 325 330 335 Asp Arg Gly Glu Leu Met Val Lys Val Ser Gly Val Lys Ala Leu Ala 340 345 350 Thr Asn Ala Ala Leu Asn He Ser Ser Gly Val Phe Glu Val He Gly 355 360 365 Ala Arg Gly Thr His Pro Arg Tyr Gly Phe Asp Arg Phe Trp Arg Asn 370 375 380 Val Arg Thr His Ser Leu His Asp Pro Val Ser Tyr Lys He Ala Asp 385 390 395 400 Val Gly Lys His Thr Leu Asn Gly Gin Tyr Pro He Pro Gly Phe Thr 405 410 415 Ser (2) INFORMATION FOR SEQ ID NO:4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 5535 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 2148..3245 ( i) SEQUENCE DESCRIPTION: SEQ ID NO:4: GCATGCACGT CGCGCCGACG CATTTGCGCG CACGGCTCCG GGCAGTTCTC GCGGCGCTGG 60 AGGCACGGAT GGGCACCCTC AACGAACTCA CCCAAACCAC GCCGATAGCG ATCCTCGCCG 120 AAACCCTCGG CTACAGCCCT CAGACATTGG AAGCTCATGC GCGACGCATC CGGATCGACC 180 TTTGCACGCT ACGTGGCGAC GCGGCTGGAC TGACGCTGGA GGTCCGACCC GACGTGTGTG 240 GTGTAGCGCC GCTTAACGGG TGCGCACGGC GGGACATCGG CCAGCTGGCT TGCCCCTCCT 300 CCGCAGGTAG TCGACCACCC CTTCCCGCAG CGGTCGGAGG TGATCGACCG TTAGGGTCAT 360 TTGCTCGCAG ATCGGCTGAT GTTGCCGATC GACGTGGTCG ACGGGACACG CTCGCGATTG 420 GCATGGCGTC CGGTGCATAC ACGACGATCT AACCAGATCG ACGGTTTTGA GCGTCGGTCA 480 ACGTCGACTC GATGCGCCGT GCGAGTGAGA TCCTTTGTGG TGCTTGGCTA TTGACCTCGA 540 CAAGGATAGA GATTCGAAGG ACCTCGGATC GACCCAAATG CGGACGGCCG GCAGCGGCGA 600 AGGCGGCCAA GTCATCGGCA CCGTCACCGT CACCTTGACC CGACGTGCCC CGTGGTTCAA 660 GGCCTGAATT TGGCTGGTGG AGCATTGAAA TCAGGTGAAG TTTAACGGTG GGCACACCCC 720 GGGGGTGGGG GTGAGACTGC TTAGCGACAG GAATCTAGCC ATGATTGACA TTTAAAGGAC 780 GCATACGCGA TGACTCAACA ACGACAAATG CATCTGGCCG GTTTCTTCTC GGCCGGCAAT 840 GTGACTCATG CACATGGGGC GTGGCGGCAC ACGGACGCGT CGAATGACTT TCTGTCGGGG 900 AAGTACTACC AACACATCGC CCGTACTCTG GAGCGCGGCA AGTTCGATCT GTTGTTTCTG 960 CCTGACGGGT TGGCCGTCGA GGACAGCTAC GGGGACAACC TGGACACCGG TGTCGGCCTG 1020 GGCGGGCAGG GTGCAGTCGC CTTGGAGCCG GCCAGTGTGG TCGCAACCAT GGCCGCGGTG 1080 ACCGAGCACC TGGGTCTTGG GGCAACCATT TCGGCGACCT ACTATCCCCC GTATCACGTT 1140 GCTCGGGTGT TCGCGACGCT CGATCAGTTG TCAGGGGGTC GGGTGTCCTG GAACGTCGTC 1200 ACCTCGCTCA ACGACGCTGA AGCGCGCAAC TTCGGCATTA ATCAGCATCT GGAACACGAC 1260 GCCCGCTATG ACCGCGCCGA TGAGTTCTTG GAAGCGGTCA AGAAACTCTG GAACAGCTGG 1320 GACGAGGACG CCCTCGTGCT GGACAAGGCG GCCGGCGTGT TCGCCGATCC CGCGAAGGTG 1380 CACTACGTCG ATCACCACGG GGAGTGGCTG AATGTGCGCG GACCTCTGCA GGTACCGCGT 1440 TCACCTCAGG GTGAGCCGGT GATCCTGCAG GCCGGCCTGT CGCCCCGGGG TCGGCGCTTC 1500 GCCGGGAAGT GGGCCGAGGC CGTCTTCAGT CTTGCACCCA ACCTCGAGGT GATGCAGGCC 1560 ACCTACCAGG GCATCAAAGC CGAGGTCGAC GCTGCGGGGC GCGATCCCGA TCAGACGAAA 1620 ATCTTCACCG CCGTGATGCC GGTACTCGGC GAAAGCCAGG CGGTGGCACA GGAACGACTG 1680 GAATATCTCA ACAGTCTGGT CCATCCGGAA GTGGGACTGT CGACGCTATC CAGTCACACC 1740 GGCATCAACC TGGCGGCGTA CCCTCTCGAC ACTCCGATCA AGGACATCCT GCGGGATCTG 1800 CAGGATCGGA ATGTCCCGAC GCAACTGCAC ATGTTCGCCG CCGCAACGCA CAGCGAAGAG 1860 CTCACGCTGG CGGAAATGGG TCGGCGCTAT GGAACCAACG TGGGGTTCGT TCCTCAGTGG 1920 GCCGGTACCG GGGAGCAGAT CGCTGACGAG CTGATCCGCC ACTTCGAGGG CGGCGCCGCG 1980 GATGGTTTCA TCATCTCTCC GGCCTTCCTG CCGGGCTCCT ACGACGAGTT CGTCGACCAG 2040 GTGGTTCCGG TTCTGCAGGA TCGCGGCTAC TTCCGCACCG AGTACCAGGG CAACACTCTG 2100 CGCGACCACT TGGGTCTGCG CGTACCACAA CTGCAAGGAC AACCTTC ATG ACA AGC 2156 Met Thr Ser 1 CGC GTC GAC CCC GCA AAC CCC GGT TCA GAA CTC GAT TCC GCC ATC CGC 2204 Arg Val Asp Pro Ala Asn Pro Gly Ser Glu Leu Asp Ser Ala He Arg 5 10 15 GAC ACA CTG ACC TAC AGC AAC TGC CCG GTA CCC AAC GCT CTG CTC ACG 2252 Asp Thr Leu Thr Tyr Ser Asn Cys Pro Val Pro Asn Ala Leu Leu Thr 20 25 30 35 GCA TCG GAA TCG GGC TTC CTC GAC GCC GCC GGC ATC GAA CTC GAC GTC 2300 Ala Ser Glu Ser Gly Phe Leu Asp Ala Ala Gly He Glu Leu Asp Val 40 45 50 CTC AGC GGC CAG CAG GGC ACG GTT CAT TTC ACC TAC GAC CAG CCT GCC 2348 Leu Ser Gly Gin Gin Gly Thr Val His Phe Thr Tyr Asp Gin Pro Ala 55 60 65 TAC ACC CGT TTT GGG GGT GAG ATC CCG CCA CTG CTC AGC GAG GGG TTG 2396 Tyr Thr Arg Phe Gly Gly Glu He Pro Pro Leu Leu Ser Glu Gly Leu 70 75 80 CGG GCA CCT GGG CGC ACG CGT CTA CTC GGC ATC ACC CCG CTC TTG GGG 2444 Arg Ala Pro Gly Arg Thr Arg Leu Leu Gly He Thr Pro Leu Leu Gly 85 90 95 CGC CAG GGC TTC TTT GTC CGC GAC GAC AGC CCG ATC ACA GCG GCC GCC 2492 Arg Gin Gly Phe Phe Val Arg Asp Asp Ser Pro He Thr Ala Ala Ala 100 105 110 115 GAC CTT GCC GGA CGT CGA ATC GGC GTC TCG GCC TCG GCA ATT CGC ATC 2540 Asp Leu Ala Gly Arg Arg He Gly Val Ser Ala Ser Ala He Arg He 120 125 130 CTG CGC GGC CAG CTG GGC GAC TAC CTC GAG TTG GAT CCC TGG CGG CAA 2588 Leu Arg Gly Gin Leu Gly Asp Tyr Leu Glu Leu Asp Pro Trp Arg Gin 135 140 145 ACG CTG GTA GCG CTG GGC TCG TGG GAG GCG CGC GCC TTG TTG CAC ACC 2636 Thr Leu Val Ala Leu Gly Ser Trp Glu Ala Arg Ala Leu Leu His Thr 150 155 160 CTT GAG CAC GGT GAA CTG GGT GTG GAC GAC GTC GAG CTG GTG CCG ATC 2684 Leu Glu His Gly Glu Leu Gly Val Asp Asp Val Glu Leu Val Pro He 165 170 175 AGC AGT CCT GGT GTC GAT GTT CCC GCT GAG CAG CTC GAA GAA TCG GCG 2732 Ser Ser Pro Gly Val Asp Val Pro Ala Glu Gin Leu Glu Glu Ser Ala 180 185 190 195 ACC GTC AAG GGT GCG GAC CTC TTT CCC GAT GTC GCC CGC GGT CAG GCC 2780 Thr Val Lys Gly Ala Asp Leu Phe Pro Asp Val Ala Arg Gly Gin Ala 200 205 210 GCG GTG TTG GCC AGC GGA GAC GTT GAC GCC CTG TAC AGT TGG CTG CCC 2828 Ala Val Leu Ala Ser Gly Asp Val Asp Ala Leu Tyr Ser Trp Leu Pro 215 220 225 TGG GCC GGG GAG TTG CAA GCC ACC GGG GCC CGC CCA GTG GTG GAT CTC 2876 Trp Ala Gly Glu Leu Gin Ala Thr Gly Ala Arg Pro Val Val Asp Leu 230 235 240 GGC CTC GAT GAG CGC AAT GCC TAC GCC AGT GTG TGG ACG GTC AGC AGC 2924 Gly Leu Asp Glu Arg Asn Ala Tyr Ala Ser Val Trp Thr Val Ser Ser 245 250 255 GGG CTG GTT CGC CAG CGA CCT GGC CTT GTT CAA CGA CTG GTC GAC GCG 2972 Gly Leu Val Arg Gin Arg Pro Gly Leu Val Gin Arg Leu Val Asp Ala 260 265 270 275 GCC GTC GAC GCC GGG CTG TGG GCA CGC GAT CAT TCC GAC GCG GTG ACC 3020 Ala Val Asp Ala Gly Leu Trp Ala Arg Asp His Ser Asp Ala Val Thr 280 285 290 AGC CTG CAC GCC GCG AAC CTG GGC GTA TCG ACC GGA GCA GTA GGC CAG 3068 Ser Leu His Ala Ala Asn Leu Gly Val Ser Thr Gly Ala Val Gly Gin 295 300 305 GGC TTC GGC GCC GAC TTC CAG CAG CGT CTG GTT CCA CGC CTG GAT CAC 3116 Gly Phe Gly Ala Asp Phe Gin Gin Arg Leu Val Pro Arg Leu Asp His 310 315 320 GAC GCC CTC GCC CTC CTG GAG CGC ACA CAG CAA TTC CTG CTC ACC AAC 3164 Asp Ala Leu Ala Leu Leu Glu Arg Thr Gin Gin Phe Leu Leu Thr Asn 325 330 335 AAC TTG CTG CAG GAA CCC GTC GCC CTC GAT CAG TGG GCG GCT CCG GAA 3212 Asn Leu Leu Gin Glu Pro Val Ala Leu Asp Gin Trp Ala Ala Pro Glu 340 345 350 355 TTT CTG AAC AAC AGC CTC AAT CGC CAC CGA TAGGAACATC CGCATGACAC 3262 Phe Leu Asn Asn Ser Leu Asn Arg His Arg 360 365 TGTCACCTGA AAAGCAGCAC GTTCGACCAC GCGACGCCGC CGACAACGAT CCCGTCGCGG 3322 TTGCCCGTGG GCTAGCCGAA AAGTGGCGAG CCACCGCCGT CGAGCGTGAT CGCGCCGGGG 3382 GTTCGGCAAC AGCCGAGCGC GAAGACCTGC GCGCGAGCGC GCTGCTGTCG CTCCTCGTCC 3442 CGCGCGAATA CGGCGGCTGG GGCGCAGACT GGCCCACCGC CATCGAGGTC GTCCGCGAAA 3502 TCGCGGCAGC CGATGGATCT TTGGGACACC TGTTCGGATA CCACCTCACC AACGCCCCGA 3562 TGATCGAACT GATCGGCTCG CAGGAACAAG AAGAACACCT GTACACCCAG ATCGCGCAGA 3622 ACAACTGGTG GACCGGAAAT GCCTCCAGCG AGAACAACAG CCACGTGCTG GACTGGAAGG 3682 TCAGCGCCAC CCCGACCGAA GACGGCGGCT ACGTGCTCAA TGGCACGAAG CACTTCTGCA 3742 GCGGCGCCAA GGGGTCGGAC CTGCTGTTCG TGTTCGGCGT CGTCCAGGAT GATTCTCCGC 3802 AGCAGGGTGC GATCATTGCT GCCGCTATCC CGACATCGCG GGCTGGCGTT ACGCCCAACG 3862 ACGACTGGGC CGCCATCGGC ATGCGGCAGA CCGACAGCGG TTCCACGGAC TTCCACAACG 3922 TCAAGGTCGA GCCTGACGAA GTGCTGGGCG CGCCCAACGC CTTCGTTCTC GCCTTCATAC 3982 AATCCGAGCG CGGCAGCCTC TTCGCGCCCA TAGCGCAATT GATCTTCGCC AACGTCTATC 4042 TGGGGATCGC GCACGGCGCA CTCGATGCCG CCAGGGAGTA CACCCGTACC CAGGCGAGGC 4102 CCTGGACACC GGCCGGTATT CAACAGGCAA CCGAGGATCC CTACACCATC CGCTCCTACG 4162 GTGAGTTCAC CATCGCATTG CAGGGAGCTG ACGCCGCCGC CCGTGAAGCG GCCCACCTGC 4222 TGCAGACGGT GTGGGACAAG GGCGACGCGC TCACCCCCGA GGACCGCGGC GAACTGATGG 4282 TGAAGGTCTC GGGAGTCAAA GCGTTGGCCA CCAACGCCGC CCTCAACATC AGCAGCGGCG 4342 TCTTCGAGGT GATCGGCGCG CGCGGAACAC ATCCCAGGTA CGGTTTCGAC CGCTTCTGGC 4402 GCAACGTGCG CACCCACTCC CTGCACGACC CGGTGTCCTA CAAGATCGCC GACGTCGGCA 4462 AGCACACCTT GAACGGTCAA TACCCGATTC CCGGCTTCAC CTCCTGAGGA TCTGAGGCGC 4522 TGATCGAGGC CGAGGCCACC GCGCGGCCGA GTCGCGAATC GCCCGCCGAT ACTCAGCTTC 4582 TCCATACGTA CGGGTGCACA CAAGGAGATA TTGTCAAGAC CTGTGGATGA GGGTGTTTCA 4642 GGCGACCTCC GTTTCGCTTG ATTCGTCGGG CTCAGCGGGT GAGATGTCGA TGGGTCGTTC 4702 GAGCAGCTTG CCTTTGTGGA ACACCGCGCC GGCACGGACC AGCGCGACCA GATGGGGGGC 4762 GTTGACCGCC GCCAGCGGGC TTGTGCGGCG TCGATCAGCT TGTAGGCCAT GGCAATCCCG 4822 CTGCGACGTG ACCCAGGGCC CTTGGTGACC TTGGTTCGCA ACCGCACGGT CGCAAACGTC 4882 GATTCGATCG GATTCGTAGT GCGCAAGTGG ATCCAGTGCT CGGCCGGGTA CCGGTAGAAC 4942 TCCAGGAGCA CGTCGGCGTC GTCGACGATC TTGGCGACCG CCTTGGGGTA CTTCGCGCCG 5002 TAATCTACCT CGAAGGCCTT GATCGCGACC TGGGCCTTGT CGATGTCCTC GGCGTTGTAG 5062 ATTTCCCGCA TCGCCGCGGT CGCACCTGGA TGAGCCGACT TGGGCAGCGC AGCAAGCACA 5122 TTGGCCTGCT TGTGAAACCA GCAGCGCTGT TCACGGGTAT CCGGAAACAC CTCCCGCAGT 5182 GCCTTCCAGA ACCCCAGCGC CCCATCACCG ACGGCCAGCA CCGGGGCGGT CATCCCGCGG 5242 CGTCGGCATG AGCGCAGCAG ATCAGCCCAC GACTCTGTGG ACTCCCGGAA CCCATCGGTG 5302 AGCGCGACGA GCTCCTTGCG GCCGTCGGCG CGGACGCCGA TCATCACGAG CAAGCACAGC 5362 TTCTCCTGCT CCAGGCGGAC ATTGAGATGG ATGCCGTCGA CCCATAGGTA CACGAAATCG 5422 GTGCCCGAGA GATCCCGGTC GGCGAAGGCC TTCGCCTCGT CCTGCCATTG CGCGGTCAGC 5482 CGGGTGATCG TCGAGGCCGA CAGCCCGGCA CCAGTGCCGA GGAACTGCTC CAA 5535 (2) INFORMATION FOR SEQ ID NO:5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 365 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: Met Thr Ser Arg Val Asp Pro Ala Asn Pro Gly Ser Glu Leu Asp Ser 1 5 10 15 Ala He Arg Asp Thr Leu Thr Tyr Ser Asn Cys Pro Val Pro Asn Ala 20 25 30 Leu Leu Thr Ala Ser Glu Ser Gly Phe Leu Asp Ala Ala Gly He Glu 35 40 45

Claims: CLAIMS 1. A recombinant DNA molecule containing a gene which encodeε a biocatalyεt capable of desulfurizing a fossil fuel which contains organic sulfur moleculeε. 2. The recombinant DNA molecule of Claim 1 wherein said fossil fuel is petroleum. 3. A recombinant DNA molecule containing a gene of a strain of Rhodococcus rhodochrous bacteria wherein said gene encodes a biocatalyst capable of desulfur- izing a foεεil fuel which contains organic sulfur molecules. 4. The recombinant DNA molecule of Claim 3 wherein the gene is derived from the IGTS8 strain of Rhodococcus rhodochrouε bacteria. 5. The recombinant DNA molecule of Claim 3 wherein εaid fossil fuel is petroleum. 6. Purified DNA derived from a εtrain of Rhodococcuε rhodochrous bacteria wherein said DNA encodes a biocatalyεt capable of desulfurizing a fosεil fuel which containε organic sulfur molecules. 7. Purified DNA of Claim 6 wherein said DNA is derived from the IGTS8 strain of Rhodococcus rhodochrous bacteria. 8. Purified DNA derived from a strain of Rhodococcus rhodochrous bacteria wherein said DNA encodes a biocatalyst capable of deεulfurizing petroleum which containε organic sulfur moleculeε. 9. Purified DNA of Claim 8 wherein said DNA is derived from the IGTS8 strain of Rhodococcus rhodochrouε bacteria. 10. A recombinant DNA vector containing a DNA molecule containing a gene which encodeε a biocatalyεt cap- able of deεulfurizing a fossil fuel which contains organic sulfur molecules. 11. A recombinant DNA vector containing a DNA molecule containing the gene of a strain of Rhodococcus rho¬ dochrouε bacteria wherein said gene encodes a bio- catalyεt capable of deεulfurizing a foεεil fuel which containε organic sulfur molecules. 12. The recombinant DNA vector of Claim 11 wherein the gene is derived from the IGTS8 strain of Rhodococcus rhodochrouε bacteria. 13. A DNA plasmid vector containing a DNA derived from a microorganism wherein said DNA encodes a biocatalyst capable of desulfurizing a fosεil fuel which con¬ tainε organic εulfur moleculeε. 14. A DNA plasmid vector containing a DNA derived from a strain of Rhodococcus rhodochrouε bacteria wherein said DNA encodeε a biocatalyst capable of desulfur¬ izing a fosεil fuel which containε organic sulfur moleculeε. 15. The DNA plaεmid vector of Claim 14 wherein the DNA iε derived from the IGTS8 εtrain of Rhodococcuε rhodochrous bacteria. 16. A DNA plasmid containing a recombinant DNA molecule containing the gene of a microorganiεm wherein εaid gene encodes a biocatalyst capable of deεulfurizing a fossil fuel which contains organic sulfur mole¬ cules. 17. A DNA plaεmid containing a recombinant DNA molecule containing the gene of a strain of Rhodococcus rho¬ dochrous bacteria wherein said gene encodes a bio¬ catalyst capable of desulfurizing a fossil fuel which contains organic sulfur molecules. 18. The DNA plasmid of Claim 17 wherein said gene is derived from the IGTS8 strain of Rhodococcus rhodo¬ chrous bacteria. 19. A DNA plasmid containing an isolated DNA derived from a strain of Rhodococcus rhodochrous bacteria wherein said DNA encodes a biocatalyst capable of deεulfurizing a foεεil fuel which containε organic sulfur molecules. 20. The DNA plaεmid of Claim 19 wherein the iεolated DNA iε derived from the IGTS8 εtrain of Rhodococcuε rhodochrouε bacteria. 21. Plasmid pTOXI-1. 22. Plasmid pTOXI-2. 23. A microorganism containing a recombinant DNA plaεmid containing a gene which expreεεeε a biocatalyst capable of desulfurizing a fossil fuel which con¬ tains organic sulfur molecules. 24. A microorganism containing a recombinant DNA plasmid containing the gene of a strain of Rhodococcus rho¬ dochrous bacteria wherein said microorganism ex- preεεeε a biocatalyεt capable of desulfurizing a fosεil fuel which containε organic εulfur moleculeε. 25. The microorganiεm of Claim 24 wherein the gene is derived from the IGTS8 strain of Rhodococcus rhodo¬ chrouε bacteria. 26. A microorganiεm containing a DNA derived from a strain of Rhodococcus rhodochrouε bacteria wherein εaid tranεformed microorganism expresses a bio¬ catalyst capable of desulfurizing a fossil fuel which contains organic εulfur moleculeε. 27. The microorganiεm of Claim 26 wherein the DNA plas¬ mid is derived from the IGTS8 strain of Rhodococcus rhodochrous bacteria. 28. Complemented host organism CPE-648 containing plas¬ mid pTOXI-1. 29. Complemented hoεt organiεm CPE-648 containing plaε¬ mid pTOXI-2. 30. A method of deεulfurizing a foεεil fuel which con¬ tains organic sulfur moleculeε through the uεe of an organiεm containing a recombinant DNA plaεmid con¬ taining a gene which expreεεeε a biocatalyεt capable of desulfurizing a fossil fuel which contains or- ganic εulfur moleculeε, comprising the steps of: a) contacting the fossil fuel with the micro¬ organism; and b) incubating the fosεil fuel and micro¬ organism mixture under conditions εuf- ficient to bring about the catalytic clea¬ vage of organic carbon-sulfur bonds, whereby the organic sulfur content of the fosεil fuel is significantly reduced. 31. A method of desulfurizing a fossil fuel which con- tains organic εulfur molecules through the use of a microorganism containing a recombinant DNA plasmid containing the gene of a strain of Rhodococcus rho¬ dochrouε bacteria wherein said microorganiεm ex¬ presses a biocatalyst capable of desulfurizing a fosεil fuel which containε organic εulfur molecules, comprising the steps of: a) contacting the fossil fuel with the micro¬ organism; and b) incubating the foεεil fuel and micro¬ organiεm mixture under conditions εuf- ficient to bring about the catalytic clea¬ vage of organic carbon-εulfur bondε, whereby the organic εulfur content of the fossil fuel is significantly reduced. 32. The transformed microorganism of Claim 31 wherein the gene is derived from the IGTS8 strain of Rhodo¬ coccus rhodochrouε bacteria. 33. A method of deεulfurizing a foεεil fuel which con¬ tainε organic sulfur moleculeε through the uεe of a microorganism containing a DNA plasmid containing DNA derived from a strain of Rhodococcus rhodochrous bacteria wherein said microorganism expresses a biocatalyst capable of desulfurizing a foεεil fuel which containε organic sulfur molecules, comprising the εteps of: a) contacting the fossil fuel with said mi¬ croorganism; and b) incubating the fossil fuel and transformed microorganism mixture under conditionε εufficient to bring about the catalytic cleavage of organic carbon-sulfur bondε, whereby the organic sulfur content of the fossil fuel is significantly reduced. 34. The method of deεulfurizing a foεsil fuel of Claim 33 wherein the fosεil fuel is petroleum. 35. The method of deεulfurizing a foεεil fuel of Claim 33 wherein the DNA iε derived from the IGTS8 εtrain of Rhodococcus rhodochrouε bacteria. 36. A nucleic acid probe capable of hybridizing to all or a portion of a recombinant DNA molecule contain¬ ing the gene of a biocatalyεt capable of deεulfur¬ izing a fossil fuel which contains organic sulfur moleculeε. 37. A nucleic acid probe capable of hybridizing to all or a portion of a recombinant DNA molecule contain¬ ing the gene of a strain of Rhodococcuε rhodochrous bacteria wherein said gene encodes a biocatalyst capable of desulfurizing a fosεil fuel which con¬ tains organic sulfur molecules. 38. A nucleic acid probe capable of hybridizing to a all or a portion of a DNA derived from a strain of Rho¬ dococcus rhodochrous bacteria wherein said DNA en¬ codes a biocatalyst capable of desulfurizing a fos¬ εil fuel which containε organic sulfur molecules. 39. The nucleic acid sequence set forth in Sequence No. 1. 40. The nucleic acid sequence set forth in Sequence No. 2. 41. The nucleic acid sequence set forth in Sequence No. 3. 42. The nucleic acid sequence set forth in Sequence No. 4. 43. The nucleic acid sequence set forth in Sequence No. 5. 44. The DNA sequence for ORF-1. 45. The DNA sequence for ORF-2. 46. The DNA sequence for ORF-3. 47. The amino acid sequence for ORF-1. 48. The amino acid sequence for ORF-2. 49. The amino acid sequence for ORF-3. 50. The DNA sequences set forth starting on page 66 through page 80.

Inventors: DENOME SYLVIA A, KOVACEVICH BRIAN R, PIDDINGTON CHRIS S, RAMBOSEK JOHN, YOUNG KEVIN D, DENOME, SYLVIA, A., KOVACEVICH, BRIAN, R., PIDDINGTON, CHRIS, S., RAMBOSEK, JOHN, YOUNG, KEVIN, D.
Applicants: DENOME SYLVIA A, ENERGY BIOSYSTEMS CORP, KOVACEVICH BRIAN R, PIDDINGTON CHRIS S, RAMBOSEK JOHN, YOUNG KEVIN D, ENERGY BIOSYSTEMS CORPORATION
Application year: 1993
Main classification: C12N15
IPC codes: C07K14, C10G32, C12N1, C12N9, C12N15, C12Q1, C12R1